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RÉSUMÉ 
L 'hyper-agrégation des globules rouges (érythrocytes) est reliée à plusieurs 
pathologies telles que la thrombose, l'anémie falcifonne, le diabète et l'athérosclérose. 
Les polymères poly (éthylène glycol) PEG et le copolymère Pluronic sont utilisés pour 
la modification de l'agrégation érythrocytaire. Pluronic est un polymère bloc amphiphile 
composé d'un bloc hydrophobe de poly(propyléthylène glycol) (pPG). Récemment, des 
inquiétudes concernant des réactions allergiques du au PPG contenu dans le Pluronic ont 
été soulevées. Par conséquent, nous avons proposé l'utilisation d'un polymère PEG 
amphiphile en fonne d'étoile composé de l'acide cholique. L'acide cholique est un 
acide biliaire naturel qui est synthétisé dans le corps humain. Ces caractéristiques 
rendent le polymère en fonne d'étoile de PEG composé de l'acide cholique (CA(PEG)4) 
très promoteur comme agent potentiel pour la réduction de l'agrégation érythrocytaire. 
Les polymères CA(pEG)4 ont été synthétisés par la polymérisation anionique. La 
structure chimique et les propriétés physiques de ces polymères ont été caractérisées par 
la chromatographie d'exclusion stérique et la diffusion de la lumière par angles 
multiples. Les rayons hydrodynamiques des polymères ont été détenninés par la 
viscosité intrinsèque en utilisant la relation d'Einstein. Les effets des polymères 
CA(pEG)4 sur la viscosité sanguine humaine et sur l'agrégation érythrocytaire ont été 
évalués et comparés aux PEGs linéaires par des mesures viscométriques et par 
agrégométrie. Les résultats de l'aggrégomètre ont démontré que le CA(PEG)4 inhibite 
l'agrégation érythrocytaire mais cependant, la réduction de la viscosité sanguine n'était 
pas significative. L'inhibition de l'agrégation érythrocytaire du polymère CA(pEG)4en 
fonne d'étoile était similaire à celle des PEGs linéaires. 
Mots-clés: polymère étoilé de PEG, agrégation des globules rouges, agrégation 
érythrocytaire, polymère PEG dérivé de l'acide cholique. 
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ABSTRACT 
Elevated red blood cell (i.e., erythrocyte) aggregation is a phenomenon closely 
related to several pathophysiological diseases such as thrombosis, diabetes, sickle cell 
disease, and athrerosclerosis. Non-ionic linear polymers such as poly(ethylene glycol) 
(PEG) and Pluronics have shown inhibitory effect against erythrocyte aggregation. 
Pluronics are amphiphilic polymers composed of a central hydrophobic moiety core, 
poly(propylethylene glycol) (pPG) tlanked by two PEGs. Recently, a number of 
concems have been raised on the allergenicity of PPG in the Pluronics. Therefore, we 
suggested the use of an amphiphilic star-shaped PEG polymer based on cholic acid core. 
Cholic acid is a natural bile acid produced in the human liver; therefore, it should confer 
more biocompatibility. These features made the cholic acid based PEG (CA(PEG)4) an 
attractive polymer to be used in the reduction of erythrocyte aggregation. The 
CA(PEG)4 polymers were synthesized by anionic polymerization. The narrow molar 
mass distribution of the star-shaped polymers was characterized by size exclusion 
chromatography alone and coupled to a multi angle laser light scattering. The addition 
of the laser to size exclusion chromatography provided additional information about the 
branching character. The hydrodynamic radius of the star-shaped CA(PEG)4 was 
calculated from their intrinsic viscosities using the Einstein viscosity relation. The 
effects of the star-shaped CA(PEG)4 on human erythrocyte aggregation and blood 
viscosity were investigated and compared to linear PEGs by me ans of viscometry 
measurements and laser aggregometry. The aggregometer data showed inhibition of 
erythrocyte aggregation for the star-shaped CA(pEG)4 polymer, however, the reduction 
in blood viscosity was not significant. Compared to linear PEGs of the same molar 
mass, the star-shaped CA(PEG)4 pol ymer inhibited red blood cell aggregation in a 
similar manner. 
Keywords : Star-shaped PEGs, red blood cell (RBC) aggregation, erythrocyte 
aggregation , cholic acid based polymers. 
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CHAPTER 1: INTRODUCTION 
Organ and tissue perfusion strongly depends on adequate blood flow. Subtle 
disturbances can lead to clinical disorders. The hyper viscosity syndrome (i.e., high blood 
viscosity) is a condition associated with hyper red blood cell (RBC) aggregation, which 
can slow down the blood flow or even stop it. This form of disorder can cause ischemia 
and thrombosis. Moreover, increased RBC aggregation has been observed and is 
implicated in the pathophysiology of numerous diseases with circulatory disorders, such 
as cardiovascular diseases, chronic and acute inflammatory diseases, diabetes, cancers, 
sickle cell disease, thalassemia and trauma.] ,2,3 In fact, several studies have pointed to 
RBC aggregability as being a strong cardiovascular risk factor.4,5 Appendix 1 describes 
the relation between RBC aggregation and sorne of the se pathologies. 
Blood viscosity can be reduced or increased when macromolecules are added to 
the suspending medium. This can cause either inhibition or promotion of RBC 
aggregation. Non-ionic macromolecules with small hydrodynamic radius, Rh « 4 nm) 
and low molar mass « 20 kDa) are known to reduce blood viscosity when added to RBC 
suspension in plasma in vitro.6 Linear Poly(ethylene glycol) (pEG) has shown to be 
beneficial in reducing RBC aggregation and blood viscosity.7 Also, an amphiphilic block 
copolymer of PEG composed of a central hydrophobic moiety core of 
poly(propylethylene glycol) (pPG) to form the compound with the general formula PEG-
PPG-PEG has been used successfully to reduce red blood cell aggregation and blood 
viscosity.8 Though it has shown promising results for the treatment of several hyper blood 
viscosity disorders (sickle cell disease and myocardial infarction), severe allergic 
reactions occurred in 30% of patients receiving intravenous infusion of PluronicS.9-11 This 
allergic reaction is thought to come from the PPG. 
Similar inhibition of red blood cell aggregation and reduction of blood viscosity 
may be achieved in an amphiphilic star-shaped PEG. The star conformation provides an 
even smaller hydrodynamic radius and lower viscosity when compared to linear PEGs 
which should make it even more efficient in reducing RBC aggregation. Indeed, as it will 
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be discussed later, a more compacted structure of polymer (smaller hydrodynamic 
radius) tends to inhibit RBC aggregation. The high density along with the dense core of 
PEG stars prevent non-specific interactions with biological systems which could lead to 
immune responses. 12 Also, cholic acid, a natural occurring compound produced in the 
human liver, has surfactant properties. The cholic acid may be used as an initiating core 
to polymerize star shaped PEG and to confer more biocompatibility to the polymer. 
Preparation of su ch amphiphilic star-shaped PEG polymers has the potential to be used as 
an intravenous injection for the treatment of hyper RBC aggregation. Thus, before we 
describe the rational behind this work, a general background on blood, RBC aggregation, 
and bile acids will be provided. 
1.1 Blood Components 
Plasma (55%) --
White blood cells 
and platelets « 1 %) -----,-"""'" 
Red blood cells (45%) 
a 
-xl00=Ht% 
b 
b 
Figure 1.1. Span hematocrit tube and components of blood. The RBC volume 
measured as the percentage of the total blood which is referred to as the hematocrit 
(Ht) and is normally around 45%.13 (Adapted from ref. 14) 
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Blood is a complex heterogeneous system composed of different types of cells and 
molecules that appears as a homogenous fluid. When blood is centrifuged and left 
standing in an anticoagulant tube there are three major parts that can be observed (Figure 
1.1). The upper layer is filled with a clear liquid that is called plasma. This fluid part of 
blood contains no cells but does contain many proteins including fibrinogen, a key protein 
involved in the clotting process and various substances (ions, sugars, lipids, hormones, 
vitamins, and dissolved gases). Below the plasma lays the buffy coat, which contains 
leukocytes (white blood cells) , and platelets, a subcellular prote in that participates in 
clotting. At the bottom of the tube are the red blood cells (RB Cs ) or erythrocytes. RBCs 
are responsible of the transportation of oxygen and carbon dioxide between the lungs and 
other tissues. The RBC volume measured as a percentage of the total blood volume is 
called the blood hematocrit (Ht). Normally it is around 45%. 13 
The RBC is a highly specialized cell who se principal role is to transport oxygen 
from the lungs to the tissues and also carbon dioxide (C02) back to the lungs. This 
function is facilitated by its biconcave shape with a typical diameter of 7-8 Ilm, a 
thickness of 2 Ilm in periphery that is less than 1 Jlm in the center.4 This disk shape 
optimizes the oxygen exchange surface with the surrounding cells. Its membrane and 
cytoskeleton are able to undergo marked deformation to pass through the capillaries that 
have 2-3 Jlm diameters. This deformation is mainly possible due to the membrane protein 
(band 3 and glycophorin) and proteins in the cytoplasma.15 The mature human RBC 
looses its nucleus during the marturation process to provide more space for the 
transportation ofhemoglobin and to facilitate the surface gas exchange. Hemoglobin (Hb) 
is an important constituent in RBC and is the molecule that complexes and transports 
oxygen in the human body. Hb is a heterodimeric tetramer composed of two a-like-
globin chains and two non-a-globin chains (P, y, or 8), conjugated to four heme groups 
(Figure 1.2). A typical erythrocyte can carry 270 millions hemoglobin molecules with 
each carrying four heme groups whose iron atoms temporary link to oxygen atoms. 16 
4 
Hemoglobin 
Figure 1.2. Tertiary structure of hernoglobin with the two p and a globin chains 
bound to four herne rnoieties. Reproduced frorn ref. 17. 
1.2 Hemorheology 
The terms blood rheology and hernorheology can be used interchangeably and 
they are concemed with the study of flow and deformation behaviour of blood and its 
constituents (i. e., RBCs, white blood cells, platelets ).15 Henceforth, crucial for the 
understanding of the rheology of blood is a basic understanding of sorne general 
principles of rheology. 
1.2.1 General principles of rheology 
Rheology is defined as the study of flow and deformation of a rnaterial normally 
exerted by an extemal force. 18 Solids deformed when a force is applied. If the 
deformation is proportional to the applied force and not too large, and if the original 
shape is retumed; the solid is said to be elastic. On the other hand, if the deformation 
rernains permanent after the force is rernoved, the solid is said to be plastic. Fluids 
continuously deform or flow because of the applied forces. Most rnaterials, including 
blood, exhibit the cornbined behaviour of both liquid and elasticity of a solid, also known 
as viscoelasticity.18 
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shear stress 
shear rate 
Figure 1.3. Parabolic velo city profile in laminar flow. The shear rate (dvldx) is the 
ratio of the velocity difference (dv) of adjacent fluid lamina to the distance between 
the fluid lamina (dx). The shear stress (FIA) is the force (F) applied per unit area (A). 
The viscosity (Tl) is the shear stress divided by the shear rate. 
The degree of deformation (or flow) of a material is re1ated to the force applied 
per unit area. This deforming force is termed stress and comprises two main components: 
(1) normal stress, the force per unit area acting perpendicular to the surface, and (2) shear 
stress, the force per unit area acting para1le1 to the surface.18 Figure 1.3 shows the 
visualization of the shear stress as the movement of hypotheticallayers sliding over each 
other. The gradient of the ve10city in the direction at right angles to the flow is called the 
shear rate (also called the ve10city gradient or strain rate). 
Under laminar flow conditions, (see Appendix 1), the shear rate-shear stress 
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re1ationship is used to describe the internal resistance between laminas or fluid layers 
which is termed, the viscosity.18 The viscosity can thus be obtained by the ratio of the 
shear stress to the shear rate (Figure 1.3). For rheological purposes, fluids can be divided 
in two main categories: Newtonian fluids and non-Newtonian fluids. In non-Newtonian 
fluids, the viscosity does not remain constant as a function of the shear rate; therefore, the 
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term apparent viscosity is preferably used to describe the viscosity at given conditions. 
In Figure 1.4, curve 1 illustrates a Newtonian fluid where the viscosity does not changes 
as a function of the shear rate; curve 2 shows a non-Newtonian fluid with a decrease in 
viscosity, which is known as shear thinning; and curve 3 shows a non-Newtonian fluid 
with an increase in viscosity, which is called shear thickening. 
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Figure 1.4. Shear stress-shear rate and viscosity-shear rate relations for 1 
Newtonian fluids and non-Newtonian fluids, where 2 represents shear thinning and 3 
represents shear thickening rheological behaviours. 
The viscosity can be affected by several parameters such as pressure, temperature, 
time, shear rate, and the molecular nature of the compound.19 The viscosity normally 
decreases with increasing temperature. The viscosity of all simple liquids decreases with 
increase in temperature because of the increasing Brownian motion of their constituent 
molecules, and generally the higher the viscosity, the greater is the rate of decrease. 18 The 
measured viscosity can either increase or decrease with time elapsed. A graduaI decrease 
of the viscosity while subjected to constant shearing followed by graduaI recovery of the 
structure when the stres~ is removed is termed thixotropy. The opposite type ofbehaviour, 
gradual increase in viscosity while subjected to constant shearing, without recovery of the 
structure is called rheopexy. 
The rheological properties of dilute polymer solutions are mainly a function of the 
concentration, temperature, molar mass, and structure of the long chain molecule. 18 
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Generally, for dilute polymer solutions its viscosity is much higher than that of the pure 
solvent. This arises because of the large differences in the size between the polymer and 
solvent molecules, and the magnitude of the viscosity increase is related to the dimension 
of the pol ymer molecules in solution. Therefore, viscosity measurements of dilute 
polymer solutions can be used to pro vide information concerning the effects upon chain 
dimensions of polymer structure, molecular shape, molar mass, and polymer-solvent 
interactions .19 
Figure 1.5. Different geometric designs that a rotational rheometer can possess: A) 
parallel plates, B) cone and plate, and C) concentric cylinders (couette). 
Several methods exist to characterize the viscosity of a solution. It can be 
measured by a viscometer, which studies the stress-strain relations. Capillary viscometers 
are mostly used to study Newtonian fluids whereas viscometers and rheometers are used 
for non-Newtonian fluids. While viscometers are limited to the measurements of viscous 
flow, rheometers are concerned with the viscoelasticity properties of semi-solids. 
Additionally, rheometers are instruments that produce deformation under controlled 
conditions representative of those found in real conditions (temperature and deformation 
rate) and measure the consequences. The consequences are usually conveyed in terms of 
stress and viscosity from which a host of rheological parameters can be further computed. 
Rotational rheometers utilized different geometric design to produce a simple continuo us 
shearing motion between two surfaces, one or both of which are rotating while measuring 
the properties offluids (Figure 1.5). 
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1.2.2 Blood viscosity 
Whole blood viscosity (RBCs, plasma, white cells, and platelets) is considered as 
a non-Newtonian suspension since its viscosity varies with the shear rate. 15 Blood can be 
viewed as a two-phase liquid, or it can also be considered as a solid-liquid suspension 
with the cellular components being the solid part. However, under shear, RBCs behave 
liquid-like and blood is considered as a liquid-liquid emulsion.15 The amount of platelets 
and white cells is so small compared to red cells that they play a minor role in the whole 
blood viscosity. However, white cells may sometimes have sorne influence as they 
specifically adhere to the vascular endothelium in certain inflammatory diseases such as 
hyperleukocytic leukaemias?O The viscosity of blood depends on plasma viscosity, 
hematocrit value, and RBC rheological properties (deformability and aggregation). These 
parameters vary considerably in several human pathological disorders. Altered blood 
rheology may have severe clinical consequences.4 
Plasma viscosity 
Since plasma is the suspending medium of the cellular constituents of blood, any 
change of its viscosity directly affects the whole blood viscosity regardless of the 
hematocrit or cellular concentration. 15 The presence of protein fractions, notably 
fibrinogen, is the major cause of blood viscosity increase, which happens in disease states 
or after tissue injury. Plasma is considered to exibit Newtonian behaviour and its viscosity 
(1.10-1.35 cP) is constant at the body temperature. However, sorne have reported non-
Newtonian behavior especially in diseased states.21 
Hematocrit value 
Under laminar flow, the presence of cellular constituents disturbing the flow 
streamlines is the main reason why whole blood viscosity (RBCs, plasma, white cells, and 
plate1ets) is higher than plasma viscosity alone. The degree of disturbance of flow 
streamlines, and consequently the viscosity of blood, strongly depends on the 
concentration of the cellular constituents or the hematocrit. 15 In general, blood viscosity 
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increase as the hematocrit increases and usually follows an exponential relationship, 
where at higher values of hematocrit; blood viscosity becomes extremely sensitive to 
hematocrit variations.22 
Red blood cell deformability and aggregation 
In addition to the concentration of the cellular constituents which disturbs the flow 
streamlines, the deformability of the RBCs under shear force is an important factor to 
consider. Normal RBCs are deformable bodies which align themselves in the direction of 
the flow. RBCs deformability and their orientation with respect to the flow streamlines 
are primary cellular factors affecting blood viscosity at high shear rates. 15 RBC 
deformability depends on the membrane and its underlying cytoskeleton: (1) the 
biconcave discoid shape, and (2) the hemoglobin concentration, both which determine its 
cytoplasmic viscosity.23 The RBC deformability affects the entrance of blood cells into 
the capillaries. This is especially a concem for RBCs with reduced deformability in 
pathological disorders such as sickle cell disease, which may sequester the capillary 
entrance. The stiffening of the cell membrane or the high concentration of Hb, which 
increases the blood viscosity may impede RBC passage through the capillaries ?4 
c 
Figure 1.6. Illustration of the deformation and aggregation of human red blood cells. a. 
observed from the surface. b. observed in profile and forming rouleaux. c Rendered 
spherical by water. d. Rendered crenate by salt solution. Taken frOID ref. 25. 
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Another important rheological properties of RBCs is their ability to aggregate 
themselves in stacks and form a reversible mass known as rouleaux, which is a primary 
factor affecting blood viscosity at low shear rates. (Figure 1.6b).21,26 
Typically, arteries and capillaries have high shear rate conditions, whereas blood 
in venules is subjected to lower shear rates. RBCs tend to aggregate and form rouleaux in 
environments of low shear rate < 10 S-l (i.e. venules), which increase blood viscosity.6 
The decrease in shear rate causes the shear stress to increase. Thus a higher pressure 
gradient is required to move the blood at low flow rates. It is worthwhile to know that a 
certain yield stress is necessary to get the RBCs to re-flow or dissagregate.27 The shear 
stress required to separate two cells in this orientation for a saline suspension of RBCs in 
4% dextran was determined by Chien and coworkers to be less than 1 dyn/cm2• 28 Upon 
flow rate increase, the shear force becomes strong enough to disrupt rouleaux. High shear 
rates above 100 S-l typically cause disaggregation of rouleaux and cell deformation, 
which in tums improve blood flow. 29 At high shear rates, the viscosity of blood is 
constant (4-5 cP) and behaves like a Newtonian fluid because the level of aggregation is 
reduced or inexistent.15 In clinical settings, RBC aggregation is mainly due to the 
increased concentration of high molecular weight plasma proteins as fibrinogen and 
immunoglobulins G and M (IgG and IgM).6,30 Other plasma proteins such as haptoglobin, 
ceruloplasmin and C reactive protein were shown to also promote aggregation?l 
1.2.3 Blood viscosity in rotational viscometers 
Blood viscosity is usually measured in a rotational viscometer, which allows the 
measurement of blood viscosity ovei" a wide range of shear rates. Rheology measurements 
are important in hemorheology since it predicts the behavior of blood flow in the vessels. 
In a static system at constant temperature, the apparent blood viscosity ('la) is a function 
of the hematocrit (Ht) and applied shear rate (n. 
'Ia= f(Ht, rJ (1.1) 
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Experimental apparatus have been designed to study the rheology of RBCs. 
They usually require blood to be sheared between two concentric cylinders (also known 
as Couette flow) or between a cone and plate, to create a constant shear across the blood 
layer (Figure I.S). It is assumed that the RBCs or aggregates are unifonnly distributed 
within the fluid layers when the viscosity measurements are obtained. 
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Figure 1.7. Illustration of the effect of the shear rate on the apparent viscosity of 
normal red blood cells (RBCs) suspended in plasma, in albumin, and in 
glutaraldehyde (to produce hardened cells). The increased in viscosity of RBCs at 
low shear rates is due mainly to RBC aggregation and the drop in viscosity at low 
shear rates is due mainly to RBC deformability. Adapted from ref. 32. 
Chien studied the behaviour of RBCs in rotational viscometers and showed that 
the increase of viscosity at low shear rate was primarily due to RBC aggregation.33 
Figure 1.7 is iIIustrative of that experiment. Chien incubated the RBCs in three media: 
saline buffer (non-aggregating medium), plasma (aggregating medium), and 
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glutaraldehyde (cell hardening medium). In glutaraldehyde, the RBCs hardened and the 
viscosity was high and constant and remained independent of the shear rate. In saline 
buffer, the viscosity of the RBCs remained almost independent of the shear rate and was 
lower than the viscosity of RBCs incubated in glutraldehyde and plasma. This showed 
that the drop of viscosity at high shear rates was due to the deformability of RBCs. 
However, at low shear rate, the viscosity of the RBCs incubated in plasma increased 
exponentially due to the aggregation of RBCs. The increase in the apparent viscosity of 
RBCs suspended in plasma was due in part to the increase in the effective particle size 
and greater trapping of plasma. As the shear rate decreased, the lower shear force acting 
on RBCs allowed the formation of aggregates, which increased the effective viscosity. At 
very low shear rates, the orientation of the cells relative to the flow was random but as the 
shear rate increased, the deformability or flexibility of red cells allowed them to orient 
themselves in a manner that presented minimal cross-section to the flow streamlines, and 
effectively reducing the apparent particle size. 
1.2.4 Mechanism of red blood cell aggregation 
There are two co-existing theoretical models to explain the process of RBC 
aggregation: bridging and depletion (Figure 1.8). Merrill et al. originally proposed the 
"Bridging Model" over thirty years ago for the plasma proteins (e.g., fibrinogen) inducing 
RBC aggregation.34 Later Chien and Jan, and Brooks27,35,36 reported that, dextran 
adsorption within neighboring RBCs also induces aggregation. 
In the bridging model, RBC aggregation is considered as a reversible process, 
which depends on the equilibrium process between several parameters: the 
macromolecular bridging force due the adsorption of macromolecules onto the adjacent 
cell surfaces (Fb) and the disaggregating forces due to electrostatic repulsion (Fe), 
mechanical shearing (Fs) and membrane strain (Fm). The net aggregating force (Fa) can be 
expressed as:34 
(1.2) 
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The bridging model postulates that RBC aggregation occurs when the bridging 
forces (Fb) exceeds the disaggregating forces (Fe, Fm, and Fs.). For instance, when RBCs 
come into close proximity, aggregates may form due to the absorption of long chains of 
macromolecules such as fibrinogen or dextran (a neutral polymer) with high molar mass 
leading to a bridging effect between cells being greater than the disaggregation forces 
(Figure 1.8). 37,38 
1- Bridging Model 
~JJ-- ' 
~---~ , 
RBC at h ig h ftow rate Macromolecules 
Bridging 
Rouleaux formation 
Aggregation 0CCllI8 when the attractive forces resulting from the adsorption 
of macromolecules onro the surface ~œeds the disagg:regating forces 
2- Depletion Model 
Depletion interaction 
Depletion of macromolecules &om the interface leads ta formation of t'ou.le.aux 
Figure 1.8. Schematic drawing of the bridging model in 1 and the depletion model in 
2. Black cylinders correspond to plasma macromolecules whereas red disks are red 
blood cells. Adapted from ref 39. 
The "depletion model" originated from Asakura and Oosawa and was applied 
later to RBC aggregation.40 This model hypothesizes that the reduced concentration or the 
exclusion of pro teins or macromolecules (e.g. dextran > 40 kDa) is near the cell surface 
of RBCs compared to suspending medium or bulk solution. This exclusion of 
macromolecules near the cell surface leads to osmotic gradient and thus depletion layer 
interaction and the tendency for adjacent red blood cells to come together (Figure 
1.8).32,41 According to this model, RBC aggregation is induced without surface adsorption 
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of macromolecules but rather results from an overlap of the depletion zones, which in 
tum causes attraction of the cens due to the osmotic pressure. 
The attraction for~ between the cells relies on the polymer concentration between 
the depletion area and the bulk solution, the thickness and density of the layer, the 
separation distance between RBCs, and the spatial properties of the macromolecules. For 
instance, when the separation distance x is much greater than the thickness of the 
depletion layer q, the force of attraction between two cells is considered negligible. The 
depletion layer q depends on the macromolecule concentration in the bulk solution and its 
molar mass. If the separation distance x is much more smaller than q, the force f of 
attraction between two cells can be described by:34 
(1.3) 
where Ris the radius of the red cell, k is the Boltzman's constant, and Tthe temperature 
gradient. 
The role of macromolecules in b100d is not a factor only affecting blood viscosity 
but in addition they regulate many cell interactions in normal and pathological conditions. 
For instance, in thrombosis formation, plasma proteins participate in platelet aggregation. 
However, in RBC aggregation, the presence of large macromolecules or plasma proteins 
is necessary for RBC aggregation because RBCs suspended in saline solution alone do 
not aggregate (see Figure 1.7) 
Both the bridging and the depletion models can explain RBC aggregation in their 
own rights and one is not necessarily better than the other. However, there is an obvious 
contradiction between both mechanisms. The bridging model predicts an increase in 
aggregation due to the increase in concentration of the macromolecules near the RBC 
surface, whereas the depletion model predicts the opposite.41 Both models suggest that the 
total adherent force between two cens is maximal when the cens are arranged "en face" 
or in rouleaux. The mechanism of RBC aggregation and disaggregation and thus the role 
of macromolecules in RBC-RBC interaction are far from being understood, especially in 
human disease states. 
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1.3 Disorders Related to Abnormal RBC Aggregation 
Microcirculatory disorders contribute a large fraction to the morbidity and 
mortality of patients and constitute a major health cost to society.42. The microcirculation 
represents the smallest vesse1s in the circulatory system and encompasses the capillary 
network with the smallest inner diameters of 4-8 !-lm, the arterioles with diameters up to 
100 !-lm, and the venules somewhat larger.42 Typically, the arterioles have a magnitude of 
ten times the shear rate of capillaries and venules have the lowest shear rate.42 The blood 
flow in the microcirculation aims to maintain vital functions such as gas and metabolite 
exchanges between capillary vessels and perfused tissues. Impaired micro circulation 
arises as a result of diseases affecting the vascular system by inflammation, which 
promotes not only leukocyte adhesions but RBC hyper-aggregation degeneration.42 
Elevated RBC aggregation is observed when high prote in fractions (e.g., fIbrinogen) are 
produced as a result of chronic infections, tissue damage, degenerative diseases, and 
cancers to name a few examples. Impaired microcirculation may have functional and 
structural impacts on the corresponding tissues or organs and these adverse effects may 
create acute and chronic symptoms such as such as ischemia and tissue infarction.42 In 
addition, the migration of RBC aggregates to the center of blood vesse1s where the shear 
rate is minimum might attenuate oxygen diffusion through the cell-free layer that is 
observed close to the vessel wall.32 A systematic consequence ofRBC hyper-aggregation 
that may be observed in conditions such as hypertension is the decrease of the blood flow 
and reduction of the cardiac output (the amount of blood being pumped out by the heart 
over a particular period of time) in severe cases. 
1.4 Blood Rheology Modifiers: Macromolecules 
As mentioned earlier, red blood cells in the presence of high molar mass 
macromolecules such as plasma proteins or polymers tend to aggregate and form 
rouleaux. The rheological effect of macromolecules on blood rheology have been 
extensively studied and reviewed. It is general knowledge that macromolecules modify 
the plasma viscosity as well as the red blood cell aggregation.6,36 Non-ionic 
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macromolecules with small radii or molar masses are known to reduce the in vitro 
blood viscosity when added to RBCs suspended in plasma.6 Non-ionic macromolecules 
known to promote RBC aggregation in vivo or in vitro include dextrans with molar 
masses ~ 70 kDa, poly( ethylene glycol) (pEG), and polyvinylpyrrolidone (PVP). 
The effect of the hydrodynamic radius of macromolecules on RBC aggregation 
was investigated by Armstrong et a16. The three non-ionic polymers that were studied 
were dextran, PEG, and PVP ranging from a molar mass of 1.5 kDa to 200 kDa. The 
hydrodynamic radius for each polymer was calculated from their intrinsic viscosities. The 
study showed that the different polymers demonstrated similar effects on RBC 
aggregation when compared on the basis of their hydrodynamic radius. Notably, aH three 
polymers with hydrodynamic radius < 4 nm inhibited RBC aggregation whereas those 
with a hydrodynamic radius > 4 nm promoted RBC aggregation. Also, the maximum 
optimal inhibitory effect was observed for polymers with hydrodynamic radius between 2 
and 3 nm. The study also showed that this trend could be applied to common plasma 
proteins such as fibrinogen and albumin. 
1.4.1 Dextran 
Dextran has been Widely used for the induction of RBC aggregation and in the 
study of RBC aggregation mechanism. Dextran was one of the fust and principal plasma 
substitutes.35,43 Dextran of MW 70 kDa with gelatin or PVP, increases the apparent blood 
viscosity with the exception of Dextran of MW 40 kDa which decreases blood viscosity.44 
Dextrans have been shown to absorb on the membrane surface of RBCs using several 
techniques such as radioactive labels.28,35 It has also been used to support the "Bridging 
Model" based on the molecular weight threshold and the rate of the absorption 
isotherms.39,45 Low molecular weight dextran is utilized in clinical practice to reduce the 
hematocrit level by hemodilution to enhance tissue perfusion and oxygenation.46 In 1963, 
low molecular weight dextran was found to prevent thrombosis (clotting of the blood).43 
However, the danger of dextran has been raised conceming renal failure and the increased 
plasma viscosity.47 
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1.4.2 Poly( ethylene glycol) (PEG) and Pluronics 
Because of their advantageous properties, PEGs have been used in a wide range of 
biomedical applications.48-50 PEG is a water-soluble polymer that is non-toxic, has a good 
clearance from the body, and is able to escape the immune system recognition.51 PEG 
may also transfer its immune properties when it is attached to another molecule.48 ThllS, a 
toxic molecule can become non-toxic when combined with PEG. Also, an hydrophobic 
moiety of a molecule can become water-soluble when coupled to PEG without loosing 
the biological properties of the drug.52 PEGs bound to lymphocyte T cells (cell-cell 
interaction molecules) was found to reduce antigenic recognition by preventing the 
adhesion ofmolecules that are involved in immune recognition and response system.53 In 
whole blood, linear PEGs with low molar mass « 20 kDa) have shown to reduce RBC 
aggregation.6 Enhance inhibiting of RBC aggregation has been reported when the 
terminal hydroxyl group of PEGs is modified to achieve covalent attachment with the 
RBC's membrane. 39,54 
Another class of polymers showing reduction of RBC aggregation is a copolymer 
of PEGs also known as Poloxamers or Pluronics (trademark names). Pluronics have two 
hydrophilic chains of PEG linked by a hydrophobic block poly(propylene glycol) (pPG) 
to form a PEG-PPG-PEG structure (Figure 1.9). In 1966, the use of the surfactant 
Poloxamer 188 (Pluronic F-68) of a molar mass of 8.4 kDa was originally suggested by 
Miyauchi et al. as a blood rheology modifier and was later found to reduce blood 
viscosity.55,56 The infusion of Pluronics F-68 (80% PEG) trademarked as RheothRx® 
intravenously was shown to reduce blood viscosity, which in turn improved blood flow to 
ischemic tissues, reduced thrombosis, and hence provided a potential treatment for 
inherited blood diseases (e.g. ischemic vascular disease and vasoocclusive crisis in sickle 
cell disease).57,58Alematively, Pluronics F-98 with a high molar mass of 13 kDa induces 
aggregation (Figure 1.10).59 
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PEG PPG PEG 
Figure 1.9. Chemical structure ofPluronics, and ABA block copolymer consisting of 
poly(ethylene glycol) (PEG) and poly(propylene glycol) (PPG) . 
(a) 
Figure 1.10. Photos by light mi~~~scopy at a magnification of 400 of (a) normal 
RBCs in plasma and (b) RBCs coated with Pluronics F98 (13 kDa). Acquired at the 
Division of Hematology and Oncology, Department of Internai Medicine of the 
University of Southern California. 
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The covalent attachment of an appropriate Pluronics to RBC surface has shown 
to be able to predict and control RBC aggregation due to the critical micellization 
temperature (CMT).59,6o Pluronics have been widely tested in several clinical researches 
and have shown great benefits in intravenous infusion. The polymer has shown to be 
beneficial in the treatment of sickle cell disease and myocardial infarction where it 
accelerates thrombolysis fonnation, thus reducing re-occlusion and ameliorating re-
perfusion injury.61,62 It can also reduce RBC aggregation in blood and decrease whole 
blood viscosity in human.63. 
Adverse non-immunoglobulin E (IgE) (class of antibodies that participates in 
allergic response) mediated hypersensitivity reactions occurred is sorne individuals 
following intravenous injection of Pluronics F-68-based pharmaceutical, most likely by 
complement activation.64 In a clinical study, Pluronic F-68 was combined with a 
perflurochemical (Fluosol-DA) for radiation treatment of tumors. Up to 30% of patients 
receiving Fluosol-DA developed hypotension and/or acute respiratory distress.9 These 
events were thought to be secondary complement activation by Poloxamer micelles. 
Recently, these adverse reactions have been classified as "complement activation-related 
pseudoallergy" and occurred after the infusion of contrast media, various drug stabilizers, 
and drug carriers, and presumably is a reflection of an individual's immune cell 
sensitivity to complement derived mediators.9,11 More recent studies by Moghimi et al 
provided evidence that Pluronic F-68 complement activation is an intrinsic property of the 
polymer and that it is independent of the polydispersity of the polymer or amount of 
contaminants, such as organic solvents (acetaldehyde and propionaldehyde) left during 
the preparations. 1 1 The complement activation was triggered at submicellar 
concentrations of the pol ymer and was partially due to the presence of allylic double 
bonds therein. 
According to this reVlew, the development of novel approaches to prevent 
Pluronic-mediated complement activation is obviously a necessity. New strategies may 
involve either biochemical modifications such as attaching an anti-body or the design of 
new therapeutic PEG-based polymer. Since biochemical modifications involves a 
thorough understanding of the specific antigen involved in Pluronic complement 
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activation which is not fully understood yet, we chose to explore the design of a novel 
PEG-based polymer. The design of the novel PEG pol ymer should have similar surfactant 
properties as Pluronic and should confer more biocompatibility or be less prone to 
allergenic reactions than Pluronic by being naturally derived. AIso, since the size of the 
polymer affects the RBC aggregation, a more compact structure should be better in 
inhibiting RBC aggregation.6 We chose the design of a novel amphiphilic star-shaped 
PEG pol ymer based on cholic acid, which is a natural occurring bile acid produced in the 
human liver. 
L5 Bile Acids and their Derivatives 
Bile acids and their derivatives are currently used for biomedical and 
supramolecular applications.65-67 A series ofthese polymers have been prepared for drug 
delivery systems,68 molecular recognition,69 dental fillings, and bone repairing 
materials.70 In particular, polymeric biomaterials with the design of an amphiphilic 
polymers with bile acid groups in the main chain or side chain, or as pendant groups or 
end groups 71-73 , have attracted significant interest because of their biodegradation 
expected to lead to the release of endogenous compounds. In fact, the in vitro exposure of 
3T3 fibroblasts, a cell line used to study the cytotoxicity of dental monomers to 
methacrylic derivatives of bile acids used as monomers in dental composites, have shown 
to be less cytotoxic than the commercial dentals.74 Such results have incited efforts to 
improve the physical and toxicological properties of polymeric biomaterials by 
incorporation of bile acids into the structure ofthese materials.75 The beneficial results of 
bile acids originate from its chemical nature, which is described in the next section. 
1.5.1 Nature of bile acids 
Bile acids are amphiphilic molecules existing in the bile of most living beings. 
They are synthesized from the oxidation of cholesterol in the liver via many enzymatic 
steps. About half of the cholesterol produced in the body is used to synthesize bile acids. 
The bile acids from humans and higher vertebrae are usually conjugated with glycine 
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(H2N-CH2-COOH) or taurine (H2N-CH2-CH2-S03H) and are stored in the 
gallbladder.76 After a meal, bile acids are released in the salt form to the small intestine to 
promote the resorption of fats and lipids.66 In total about 20-30 mg of bile acids are 
secreted in the small intestine.77 Then, they are either excreted or reabsorbed through the 
ileum naphthal in the enterohepatic circulation to be reused again. Their function is vital 
in the emulsification offats, and membrane transports of vitamins. 
Bile acids made in the liver from cholesterol are referred as "primary bile acids" 
and those produced by the action of intestinal bacteria during the enterohepatic pathway 
of bile acids are called "secondary bile acids". Secondary bile acids may be subject to 
further structural transformation by liver enzymes and thus ar.e referred to as "tertiary bile 
acids". Cholic acid and chenodeoxycholic acid are primary bile acids; lithocholic acid and 
ursodeoxycholic acid are secondary and tertiary bile acids, respectively (Figure 1.11). 
The human bile acid pool has about 2.5-5 g of bile acids, compromising mainly -90% of 
cholic acid, chenodeoxycholic acid and deoxycholic acid in a ratio of about 2:2:1 and 
ursodeoxycholic acid and lithocholic acid are found in the remaining 10% of the poo1.68 
Cholic acid (CA) is one of the most abundant bile acids in our body and is 
relatively easy to obtain. It is also considered useful in the synthe sis of new prodrugs for 
liver-specific drug targeting and improved intestinal absorption.78 The incorporation of a 
biocompound such as CA into polymers may lead to the improvement of the biological 
compatibility, activity, and safety of the materials in biomedical applications.79,8o 
In contrast to other bile acids, CA has four functional groups. The steroid 
possesses also an asymmetry meaning that no two positions are equivalent. For instance, 
the C3-0H is equatorial while the others are axial, allowing the former to possess fast 
chemical reactivity and to be derivatized selectively (Figure 1.12).81 
o 
Cholesterol 
011 
(L) 
Chclesterol-7 a-
nydroltytasO HO 
H 
Cholicacid 
o 
22 
o 
OH OH 
o 
H 
Chenodeoxycholic acid 
-S~~~nd~~--- --- --/( --- --- -- ---- -- -- -- -- ------7( -- -- --- --- --~- -----------~- --
OH OH OH 
H H 
Deoxycholic acid lithocholic acid 7-Qxo-lithocholic acid 
~ 1 l~~ 
-T;~i~~· ----. --------------. --------------1---------~---------------------r ----------; --
~ l~ 
H 
HO" 
H 
Uthoçholic acid sulphate Ursodeoxycholic acid 
Figure 1.11. Bile acid metabolism: production of primary, secondary and tertiary 
bile acids occurs in the liver (L) and by intestinal bacteria (lB). Adapted from ref.68 
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1.5.2 Properties of bile acids 
The chemistry of bile acids involves the usual reactions for hydroxyl and 
carboxylic groups. However, the rates at which each hydroxylic group reacts differ from 
each other and merit further elaboration. The hydroxyl groups may be oxidized or 
esterified with a variety of reagents. The order by which each hydroxyl group reacts is 
dependent on its position. The order of reactivity is C7 > C l2 > C\3, and C6 > C3.76 The 
order of ease for acetylation, reduction, and hydrolysis is quite different. The order of 
reactivity is C3 > C7 > Cn.76 
The reactions of the terminal carboxyl group are typical of this group and involve 
the esterification which is a classic reaction to protect against the oxidative and reductive 
reactions in the preparation of bile acids. Also, esters tend to crystallize more easily than 
in therr natural state.82 Other reactions with the carboxyl. group include the formation of 
complex compounds with salt and conjugation with amino acids moiety by first coupling 
the carboxylic acid with azide or mixed anhydride. 
Due to their unique structure with a hydrophobic p-side and a hydrophilic a-si de, 
bile acids possess detergent and cleaning properties which differ from typical surfactants, 
which have a polar head and an alkyl chain. The facial amphiphilicity of the bile acids is 
provided by their rigid steroid backbone from having aIl the hydroxyl and the carboxylic 
groups on one side of the molecule (Figure 1.12). 
In a very dilute medium, these amphiphilic molecules are present as monomers 
and as the concentration increases the se molecules form micelles at which the surface 
tension, electrical conductivity, viscosity, light scattering, and other properties abruptly 
change. Micelles are aggregates of amphiphilic molecules in water; the aggregation of 
these molecules is spontaneous above a well defined concentration known as critical 
micellization concentration (CMC).83 The micelles are formed by the delicate balance of 
opposing forceswhich result in aggregates that solubilize fats. Depending on the pH, 
presence of ions, and temperature, bile acids easily form micelles in water at 
concentrations of O~6-10 mM; this is of central importance for their physiological' 
function.68 
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Figure 1.12. The chemical structure ofbile acids. 
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In general, micelles may be cylindrical or spherical depending on the 
configuration of the molecule. For instance, soaps usually adapt a spherical structure 
whereas bile acid micelles are almost cylindrical or even more complex structures for 
secondary micelles.76 During the formation of micelles in an aqueous environment, the 
center of the spherical or cylindrical structure contains the hydrophobic moiety of the 
amphiphilic molecule and the outer layer containing the carboxylic and hydroxylic groups 
forms the hydrophilic moiety, which interacts with the water molecules. If the hydroxylic 
groups on the micelles are ionized, they attract ions on them, which in turn neutralize the 
charges on the micelle. In general, the micelles have a net charge and migrate in the 
direction of the electrostatic field. 77 
Therefore, the hydrophobicity of the cholane core -as weIl as the amphiphilic 
properties and micelle formation of the bile acids may provide interesting characteristics 
when combined to PEG. 
1.5.3 Polymers based on bile acids 
The synthesis of a variety of bile acid derivatives has been described.67,75,81 Most 
of the substances were developed in searching novel compounds with pharmaceutical and 
biomedical applications including their treatment in the bile acid deficiency and liver 
disease and their dissolution in cholesterol gallstones. 
In our group, we have synthesized hydrogel polymers with bile acid derivates to 
improve their properties. For instance, hydrogel polymers of methacrylate and 
methacrylamide derivatives of cholic acid were made by radical polymerization of the 
hydroxyl group on position C3 (Figure 1.13 a).86,87 Depending of the design and intended 
application, the bond at position C3 was either a p or an a configuration. The introduction 
of the 3-amino group instead of the 3-hydroxy group was carried out to improve the 
hydrophilicity of the monomer from ester to amide (Figure 1.13 b). However, the 
hydrophobicity was still predominant in the polymer. 88,89 In effort to improve the 
hydrophilicity of the se methacryloy polymers, a flexible spacer group, ethylene glycol 
(EG) was introduced, and with variable length of EG or oligomers the water content 
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increased (Figure 1.13 c). 79 The hydrophilicity of these methacrylate esters and 
methacrylamide of cholic acids can subsequently be increased by copolymerization with 
even more hydrophilic comonomers such as methacrylic acid (MAA) and hydroxyethyl 
methacrylate (HEMA).81 Sorne of these polymers were modified and their liquid crystal 
properties where the bile acids represent the mesogenic unit were synthesized.90 
CH3 tCH2::::6-~ ~FCH2CH2tnO 
o 
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Figure 1.13. Structure of sorne cholic acid derivatives. 
Living polymerization methods such as atom transfer radical polymerization 
(ATRP) have been used in the preparation of super-branched or combed-shaped polymers 
containing CA and poly(methacryloyl tri( ethylene glycol)) with much better structural 
control than the conventional radical polymerizations.78 These combed-shaped polymers 
have shown to have semicrystalline properties and high glass transition temperature (Tg) 
caused by the bulky and hydroxy-containing CA residues in high density, factors that tend 
to raise Tg of polymers. 
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Star-shaped amphiphilic polymers 
The design of amphiphilic star-shaped polymers is of growing interest for 
biomedical, pharmaceutical and biotechnology applications because these polymers can 
behave as unimolecular micelles or be designed to exhibit a very low critical aggregation 
concentration (CAC).91,92 
Star-shaped polymer exhibit smaller hydrodynamic radius and lower solution 
viscosities as compared to the linear polymer of same molecular weight.93 More 
importantly, star polymers with multiple end groups may confer even more advantages by 
being functionalized for a variety of applications. These features are very attractive for 
biomedical applications such as micellar drug delivery and thermoplastic hydrogelS.94,95 
The amphiphilic polymers are generally produced by modifying hydrophilic 
polymers such as dextran, polysaccharides, chitosan, and heparin by covalently attaching 
a bile acid through its carboxylic group (at position C24) or its hydroxyl groups 
(preferably position C3).96 These water-soluble polymers containing bile acids as pendant 
groups are able to form micelles in water, which is a desirable property for drug delivery 
vectors. Micelles as drug delivery vectors are able to provide a set of unbeatable 
advantages: they can solubilize poorly soluble drugs and thus increase their 
bioavailability; they can stay in the blood circulation long enough providing graduaI 
accumulation in the required area; their size permits them to accumulate in body regions 
with leaky vasculature; they can be targeted by attachment of a specific ligand to the 
outer surface; and they can be prepared in large quantities easily and reproducibly.97 
Being in a micellar form, the drug (poorly soluble drug) is well protected from possible 
inactivation under the effect of biological systems, it does not provoke undesirable side 
effects, and its bioavailability is usually increased. When bile acids are part of a water-
soluble polymer, the resulting amphiphilic polymer might exhibit a better compatibility 
with biological systems and interact favorably with proteins, enzymes, or lipids.98 
These polymers are mainly synthesized by copolymerization of two monomers: 
one water repellent such as PPG and the other water-soluble such as PEG. The other 
process usually involves the chemical attachment of an existing hydrophilic polymer 
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through attachment of hydrophobie moiety. Since bile acids show limited solubility in 
their acid form in water and exhibit surface-active properties in their sodium salt form, 
their hydrophibicity makes them attractive compounds for the preparation of amphiphilic 
polymers in which they are incorporated as the hydrophobic segment.99 
Star polymers, which a number of linear arms of similar MW emanate from a 
central core, have drawn recent interest due to their compact structure and their 
interesting rheological properties. lOo Star-shaped polymers with a choUc acid core have 
been prepared in our laboratory by ATRP with well controlled molar masses. IOI The 
modified carboxylic group at position C24 along with the hydroxyl groups on positions 
C3, C7, and C12 were used to initiate the polymerization of tert-butyl acrylate (Figure 
1.14). 
MeOH l 
OH 
Br~r l 
o 
OH 
OCOC(CH3)Br 
Figure 1.14. Atom transfer radical polymerization initiator from cholic acid. 
Hydrolysis of the tert-butyl groups affords a star-shaped polymer. 
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1.6 The main objectives 
As mentioned in the introduction, elevated RBC aggregation, which increases 
blood viscosity, is a strong pathophysiological factor affecting many cardiovascular 
diseases. Block copolymers of PEG, poloxamers or Pluronics, which reduce RBC 
aggregation, have shown to induce adverse reactions in sorne patients. Hence, enhancing 
the biocompatibility by changing its molecular architecture and growing PEG onto a 
biocompatible core, such as a bile acid that is naturally found in the body, should increase 
its biocompatibility. When such natural biocompounds are introduced or used in the 
preparation of the polymer materials, they should be better tolerated biologically because 
of their amphiphilic properties, which allow the polymer to interact favorably with the 
biological environment. Even in case of a possible breakdown of the polymers, it is less 
likely to cause toxic effects; hence allergic reactions should be less of a concem. AIso, a 
star shaped polymer is preferred because a small compact structure should be better at 
reducing blood viscosity because of its low solution viscosity compared to linear 
polymers of the same molecular nature. Therefore, we proposed the use of a star-shaped 
amphiphilic PEG polymer with cholic acid derivative as core, as a therapeutic polymer 
for inhibiting RBC aggregation. 
In order to frnd an appropriate molar mass of the star-shaped polymer that might 
be more effective in reducing RBC aggregation and to have controlled chain lengths, 
several polymers of different molar masses have been prepared via living anionic 
polyinerization. These star-shaped polymers were characterized by nuclear magnetic 
resonance spectroscopy, size exclusion chromatography, and thennal analysis. 
Rheological analysis and viscosity measurements were used to evaluate their solution 
viscosities. 
Herein, we wish to assess the effect of the star-shaped PEG with a cholane core on 
RBC aggregation. To evaluate the extent of the inhibition of RBC aggregation, two 
experimental approaches were used: viscosity measurements and laser aggregometry. The 
results will be compared to linear counterparts and to reactive PEGs, which are covalently 
linked to the RBC membrane to study its effectiveness. 
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CHAPTER 2: EXPERIMENTAL PROTOCOLS 
In this chapter, the preparation of the polymers and the characterization methods 
used for this study are addressed. Then, we present the methodologies used to evaluate 
the effect of the polymers on blood viscosity. 
2.1 Preparation of Star-Shaped Polymers with a Cholane Core 
2.1.1 Description of the experimental techniques 
Anionic polymerization technique has been developed to allow the controlled 
synthesis of polymers with a variety of structures. This type of polymerization produces 
polymers with similar chain length or narrow molar mass distribution, which is termed 
living or chain-termination-free. Thus, living anionic polymerization is our chosen 
technique to synthesize well-controlled molar mass and molar mass distribution star-
shaped polymers. 
However, anionic polymerization must be conducted under inert conditions 
because of the sensitivity of the initiating system and the resulting chain ends to the traces 
of air and water. Therefore, very rigorous experimental conditions must be utilized in 
order to achieve quantitative results. For this purpose, a special setup with a high-vacuum 
and argon purification and special apparatus are required to exclude all impurities that 
may interfere with the polymerization reaction. The experimental setup is shown in 
Figure 2.1. This system is primarily composed of an oil pump capable of producing a 
strong vacuum and an argon line. The pressurized argon passes through a column filled 
with drying agents (silica) and then, the gas passes through the manifold. Afterwards, the 
gas passes through a pressure release system that is controlled via a stopcock, which is 
connected to the mineral oil bubbler. The pressure release device is simply a needle 
syringe in an Erlenmeyer flask sealed with a septum and copper wires. However, there is 
always the danger of pressure building up to the point of fracturing the apparatus when 
gases are used in a vacuum system. Consequently, a slight pressure difference is required 
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to facilitate the diffusion of gas or the transfer of intermediates into another tlask. Thus, 
the purpose of the pressure release system serves to relieve such pressure in the apparatus 
while maintain an air-tight system. 
Vacuwn line 
The pressure 
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Figure 2.1. Setup for the anionic polymerization with the argon, manifold and the 
vacuum pump system. 
Treatment of glassware 
Flasks, reactors, and ot1:ter glassware were washed with chromic acid cleaning 
solution (caution, very corrosive), and then rinsed with distilled water followed by an 
acetone-wash, to be finally dried in an oven at over 100°C. After removal from the oven, 
the cleaned glassware was connected to the manifold and evacuated with the vacuum line. 
The glassware was heated with a hand torch adjusted to give a white to blue flame until 
the yellow flame was given off from the glass surface. During the heating process, the 
glassware was continually being evacuated, then, aIlowed to cool down foIIowed by a 
stream of argon gas. This cycle was repeated at least three times. 
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2.1.2 Materials 
Solvent Purification 
Tetrahydrofuran (THF) (> 99%, Aldrich) was purified by distillation with a 
heating mantle over sodium metal (Aldrich) and benzophenone (Aldrich) through a 
distillation column, which was connected to an argon line. The appearance of the 
characteristic blue color indicated that the THF was dried. The THF was coUected in a 
flask into which smalilumps of potassium (98% in minerai oH, Aldrich) and naphthalene 
(Aldrich) were added to obtain a concentration varying from 0.24 - 0.50 M depending on 
the preparation. The flask containing the initiator solution was sealed and stored at 4°C. 
The concentration was determined by titration with a standard solution of 0.05 N HCL 
Ethylene oxide (EO) was purchased from Aldrich and was dried by passing 
through a calcium hydride column and the EO vapors were condensed by using a cold 
trap where a dry ice-acetone bath was used. EO was subsequently distilled in 1.6 M n-
butyl lithium solution in hexanes (Aldrich). Dimethylsulfoxide (DMSO from Aldrich) 
was dried overnight with calcium hydride and subsequently distilled just before the 
polymerization and transferred to the reaction flask under argon gas prior to use. Cholic 
acid (98%, CA) and aminoethanol (98%) was purchased from Aldrich and used as 
received. 
2.1.3 Preparation of cholic acid methyl ester (CAME) 
The esterification of cholic acid (CA) was achieved according to a previously 
published method and is briefly discussed here.102 CA was weighed (7.31 g, 18 mmol) 
and added directly to a 250 mL round bottom flask. Methanol was added (70 mL) to the 
reaction flask with a few (3-5) drops of concentrated HCL The reaction vessel was 
equipped with a distillation column and a magnetic stirring bar. The mixture was refluxed 
and stirred for 6 hours at 65°C in an oH bath. The flask was cooled down at room 
temperature and placed in a refrigerator at 4°C overnight to precipita te the crystals. The 
crystals were filtered and washed 3 times with chilled methanoL The crystals were dried 
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overnight under reduced pressure to remove any residual methanol. The yield of the 
product was 95%. lH NMR (400 MHz, CDCb, ppm): ô = 0.68 (3H, s, Cl8-CH3), 0.89 
(3H, s, Cl9-CH3), 0.98 (3H, d, J = 6.2 Hz, C2l-CH3), 3.42 (lH, m, C3-COH), 3.66 (3H, 
s, C24-0CH3), 3.85 (lH, s, C7-CH), 3.98 (lH, s, Cl2-CH), 1.0-2.5 (various CH and 
CH2). 
2.1.4 Preparation of (2'-hydroxylethylene)-3a,7a,12a -trihydroxy-5Ji-
cholanoamide (CA-NHCH2CH20H) 
In a 250 mL reaction flask equipped with a distillation column, 5 g of CAME (l2 
mmol) was added with 30 mL of 2-aminoethanol. The mixture was stirred at 90°C. The 
reaction was monitored with thin layer chromatography (TLC). After 4 hours, the reaction 
was cooled to room temperature. A 50:50 mixture of ice and water was poured into the 
reaction flask to yield a milky white precipitate. The precipitate was filtered and was 
recrystalized by adding hot methanol until it dissolved and then, ethyl acetate was added 
in excess. The final product was dried in the oven under vacuum. The yield of the product 
was 90%. lH NMR (400 MHz, DMSO-~, ppm): Ô = 0.58 (3H, s, C18-CH3), 0.81 (3H, s, 
C19-CH3), 0.92 (3H, d, J = 6.4 Hz, C2l-CH3), 1.0-2.2 (m, protons on the steroidal 
skeleton backbone), 3.08 (2H, q, J = 6.04 Hz, C25-NCH2), 3.18 (lH, m, C3-CH), 3.35 
(2H, m, C26-CH20), 3.60 (lH, s, C7-CH), 3.77 (lH, s, Cl2-CH), 4.01 (lH, d, J = 3.3 Hz, 
Cl2-COH), 4.10 (lH, d, J = 3.5 Hz, C7-COH), 4.32 (lH, d, J = 4.3 Hz, C3-COH), 4.62 
(lH, t, J = 5.5 Hz, 26-COH), 7.75 (lH, t, J = 5.5 Hz, 24-CONH). 
2.1.5 Anionic polymerization of ethylene oxide 
Several samples of different molar mass of star-shaped PEG polymers with a 
cholic acid core (CA(PEG)4) polymer were obtained according to the synthetic route 
shown in Figure 2.2. The cholane derivative, CA-NHCH2CH20H was weighed and then 
added to the reactor vessel under argon gas. Then, a low vacuum was introduced for a few 
minutes to remove any moi sture residual before being placed under argon gas once again. 
Then, 90 mL of freshly dried DMSO was subsequently added to the reactor vessel via a 
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canula and the solution was stirred with a magnetic stirring bar. The Solution was c1ear 
and colorless 
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Figure 2.2. Synthe sis route for CA(PEG)4 star polymers. 
A calculated amount of initiator to reach a 25% deprotonation (potassium 
naphthalene solution in THF) was collected in a graduated cylinder (see Figure 2.1) by 
pressure difference with argon gas by using a canula. This step is crucial because any leak 
in the system can deactivate the initiator and caution must be taken to avoid introducing 
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excess amount of initiator into the reactor vessel, which may lead to the activation of 
small PEG chains. In order to transfer the initiator from the graduated cylinder into the 
reactor vessel, the pressure was reduced in the reactor vessel by connecting it to a canula 
via the pressure release system (see Figure 2.1). Then, the initiator was added dropwise 
into the reactor vessel via a canula using high pressure of argon. After the transfer of the 
initiator, the reactor vessel was placed back under a stream of argon. The mixture quickly 
became dark green, which persisted for a few minutes until it became clear and colorless 
again. At this stage, if the dark green color disappeared too quickly, it usually meant that 
sorne contaminants were present in the reactor vessel and that the desired molar mass 
would not be attained. In the special apparatus composed of a graduated cylinder 
connected to a round bottom flask (see Figure 2.1), a vacuum was introduced just for a 
few seconds and then closed before ~ 5 mL of tert-butyllithium was introduced into the 
round bottom flask part via a canula. Then, the tert-butyllithium was cooled down with a 
dry ice-acetone bath. The graduated cylinder of the special apparatus was also placed in 
the dry ice-acetone bath. With a low vacuum on, a predetermined amount of ethylene 
oxide (EO) was collected directly in the special apparatus with the graduated cylinder and 
then, the vacuum line was closed. For instance, to synthesize a 15 kDa star-shaped 
polymer, the amount of mL ofEO was calculated using the following formula: 
mL of EO = 0.75 mmol A x 4x 83 equivof PEO x 44.05 g/mol 
0.882g/ml 
where A is the molar concentration of CA-NHCH2CH20H (MW of 451.65 g/mol) 
4 is the number of arms of the star-shaped polymer 
83 is the equivalence of EO units per arm 
44.05 g/mol is the MW ofEO 
0.882 g/mL is the density ofEO gas. 
(2.1) 
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The graduated cylinder of the special apparatus was placed in dry ice-acetone 
bath to distill EO in the flask. Distillation was aided by wetting a paper towel with dry 
ice-acetone bath and brushing the side walls of the apparatus so that EO could distill in 
the flask faster. This step was very useful especially when large amounts (> 10 mL) of 
EO had to be distilled. Normally, it could take up to thirty minutes or even an hour for the 
vapors of EO to condense in the graduated cylinder. In the meantime, the [ert-butyl 
lithum line was closed. When the desired amount of EO was collected, the tert-butyl line 
was opened. It is noted here that an excess of 1 or 2 mL of EO was added to the 
calculated amount of EO so that it could compensate for the EO loss during transfer. The 
EO was distilled into the tert-butyllithium flask by warming it from the contact with a 
hand or with the aid of warm water in a beaker and cooling the receiving end of the flask 
with dry ice-acetone bath. After drying EO with tert-butyllithium, it was transferred back 
into the modified graduated cylinder by cooling the receiving end and warming the round 
bottom flask. Gloves were wom at all times during the transfer process. In the meantime, 
the reactor vessel containing the DSMO solution was also cooled down with a dry ice-
acetone bath so that when the EO would be transferred, it would not be evaporated. The 
EO was transferred to the DMSO solution in the same manner as the initiator. The DMSO 
solution was mixed well and let warmed back to room temperature before heating. The 
polymerization proceeded at 40°C for 48 hours and the argon feeding line was closed. 
The reaction mixture was quenched with a few drops of concentrated HCl until the pH 
paper indicated a neutral pH value. Then, the DMSO solution was extracted 3 times with 
hexane to remove the naphthalene residuals and after it was evaporated under vacuum, 
THF was added to dissolve the polymer until the salt appeared, which was then filtered 
out of the solution. The THF was also removed under vacuum. The viscous polymer 
solution was purified by several solvent extractions with THF and diethylether to yield a 
white to yellow powder. The polymers synthesized are listed in Table 2.1 and will be 
referred to by their sample number through out this manuscript. 
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Table 2.1. List of the four armed star-shaped PEG polymer with acholie acid 
core synthesized by anionic polymerization 
Sample EO uoits MolarMass (X4arms) 
106 19.1 kDa 
2 84 15.3 kDa 
3 69 12.6 kDa 
4 55 10.1 kDa 
5 51 9.5 kDa 
6 40 7.5 kDa 
7 39 7.3 kDa 
8 32 6.0kDa 
9 26 5.0kDa 
10 25 4.8kDa 
Il 20 4.0 kDa 
12 17 3.5 kDa 
13 16 3.4 kDa 
14 15 3.2 kDa 
15 11 2.4 kDa 
16 8 1.8 kDa 
17 7 1.6 kDa 
18 5 1.3 kDa 
2.2 Characterization Methods 
Nuclear magnetic resonance (NMR) spectroscopy 
IH NMR spectra of the CA(PEG)4 polymers and cholic acid derivatives were 
recorded on a Bruker AMX400 spectrometer operating at 400 MHz for IH. The cholic 
methyl ester (CAME) was dissolved in deuterated chloroform (CDe!) with a peak that 
appears at 7.24 ppm) and the other compounds were dissolved in deuterated dimethyl 
sulfoxide (DMSO-<4; with a solvent peak at 2.5 ppm). 
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Differentiai scanning calorimetry (DSC) 
The thennal transitions of the polymers were analyzed on a TA DSC QI 000 
differential scanning calorimeter (DSC). A precise amount of polymer between 3-10 mg 
was placed in an aluminum capsule under a nitrogen atmosphere with a tlow of 50 
mL/min. The heating rate was 10°C/min and the data were treated using a Thennal 
Analysis 2000 system. See Appendix 2 for more details. 
Matrix-assisted laser desorptionlionization time-of-flight (MALDJ-TOF) mass 
spectrometry 
MALDI-TOF mass spectrometry was carried out on a Bruker Daltonics Autoflex 
MALDI-TOF mass spectrometer. The instrument is equipped with a standard nitrogen 
laser (À.=337 nm) to desorb and ionize the samples. The instrument was operated in the 
positive ion linear mode with an accelerating potential of +20 kV. Ali spectra were 
collected with an average of 200 shots. AH samples were analyzed with dithranol (l,8-
dihydroxy-9[IOH]-anthralenone, Sigma) as the matrix and LiCl was used as the saturated 
salt solution. About 10 mg of dithranol was dissolved in 0.5 mL of methanol to prepare a 
saturated solution and 10 mg of LiCl was dissolved in 1.5 mL methanol. The pol ymer 
solutions were prepared by dissolving 2.5 mg of the polymer in 0.5 mL methanol. The 
final mixture solutions were prepared with the following mixing fonnula: 
20 f..lL of matrix + 2 f..lL of a polymer solution + 2 f..lL of Liel solution 
Then, 0.5 to 1 f..lL of sample solution was deposited on the sample plate and air-dried. A 
peptide (1 to 4 kDa) and a protein (3 to 25 kDa) calibration standard were used to 
calibrate the molar masses of the star polymers. 
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Size exclusion chromatography (SEC) 
Size exclusion chromatography (SEC) was performed on a Breeze system from 
Waters equipped with a 717 auto sampler and a 1525 Binary HPLC pump. The 
chromatogram was recorded at a flow rate of 1 mL/min in THF at 25°C, and a Waters 
2414 system with a refractive index detector installed with three Styragel columns HR3, 
HR4 and HR6 (all three 7.8 x 300 mm) in series (from Waters) were used for the 
resolution of the different samples. About 2 mg of polymer were dissolved in 1 mL of 
THF. The calibration curve was made with linear PEGs standards (Polymer Laboratories 
L TD) with molar mass of 1900, 6450, Il 840, and 22 450 kDa. About 5 mg of each PEG 
standards were dissolved in 5 mL of THF. However, if star-shaped PEGs standards were 
available they would be preferable than linear PEGs since they would have a similar 
hydrodynamic radius. The linear calibration curve was extrapolated to estimate the 
number-average molar mass (Mn) and the weight-average molar mass (Mw) of the 
polymers (See Appendix 2). 
Light scattering (LS) experiments for the determination of Mw of the CA(pEG)4 
polymers and PEG standards (Polymer Laboratories L TD) were performed on a 
chromatographie system consisting of a Waters 510 HPLC pump, pre-guard + two 
columns (PLAquagel-OH-30 8 !lm, 103 A and 105 A), a Dawn EOS multi-angle light 
scattering detector (À = 690 nm), coupled to a Optilab Rex refractive index detector, and a 
Wyatt QELS quasi elastic light scattering, all from Wyatt Technology Corporation. Data 
were collected and analyzed by the ASTRA software (Wyatt Technology Corporation). 
The dnldc (differential refractive index increment) was determined online assuming a 
total mass recovery or offiine by determining the refractive index at several 
concentrations. Water and phosphate buffer solution (PBS) at a flow rate of 1 mL/min 
were used at the mobile phase and 0.05% of sodium azide was added to prevent bacteria 
formation. The normalization and the alignment of the instrument were carried out by 
PEG standards, Pullulan-5 and Pullulan-lOO using rms radii of 2 nm and 10 nm, 
respective1y.103 About 10 mg of pol ymer was dissolved in 1 mL ofwater or PBS to get a 
good signal from the light scattering detector. 
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Viscosity measurements 
Viscosity measurements were made with the Viscosity Monitoring Electronic 
instrument (Cambridge Applied Systems) at 25°C to determine the hydrodynamic radius 
(Rh) of the synthesized polymers. Solutions of CA(PEG)4 polymers in doubly distilled 
water were prepared and left standing at room temperature in a sealed vial for 24 hours to 
get clear solutions. The viscosity measurements for each solution were measured five 
times. 
Rheology measurements were made on an AR2000 rheometer (TA Instruments) 
using a couette measuring cell. Solutions of star-shaped CA(pEG)4 polymers in water and 
in PBS (10 mL) for different MW were prepared to study the effect of shear rate on the 
viscosity at 25 and 37°C. The rheological measurements of continuous and steady states 
were recorded. 
2.3 Blood-Related Experiments 
The effect of the CA(pEG)4 polymers and linear PEGs on RBC aggregation was 
studied with Contraves LS-30 couette viscometer, Myrenne aggregometer and direct 
microscopie techniques. Because of the non-conclusive results of preliminary 
experiments, expertise was sought and measurements were performed at the Department 
of Physiology and Biophysics of Kerck School of Medicine at the University of South 
California by Dr. Armstrong. 
2.3.1 Materials 
The CA(PEG)4 and the linear PEGs polymers used for the in vitro studies of their 
effect on RBC aggregation and their molar mass are listed in Table 2.2. Their molar 
masses were measured by size exclusion chromatography in THF and the molar mass of 
the linear PEGs cornes from the specification of the manufacturing companies. 
o 
o 
mPEG-succunimidyl proponiate (mPEG-SPA) 
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Figure 2.3. Structure of monomethoxy PEG succinimidyl propionate (mPEG-SPA) 
Also, a monofunctional succinimidyl propionate derivative of monomethoxy PEG 
(mPEG-SPA) from Nef/car Therapeutics of molar mass of 20 kDa was used as an 
appropriate positive control for polymer binding to the: RBC's membrane (Figure 2.3). 
Table 2.2. Linear and star-shaped PEG polymers with a cholic acid core (CA(PEG)4) 
that were used to evaluate their effect on red blood cell aggregation. 
Samples EO uoits Mo Mw PDI 4 
1 106 19110 19340 1.01 
2 84 15320 16050 1.05 
3 69 12660 13 120 1.04 
4 55 10080 10600 1.05 
5 51 9500 9970 1.05 
11 20 4040 4230 1.04 
PEG-2k (Fluka) 1900 1960 1.03 
PEG-5k (Sigma) 5120 5240 1.03 
PEG-7k (Sigma) 6850 7000 1.03 
PEG-12k (Fluka) 10 800 11250 1.04 
PEG-22.8k 21500 22800 1.06 (Polymer Labs Standard) 
mPEG-SP A ( Netkar 20000 
Therapeutics) 
For samples 1 to 5, and Il, the molar mass were determined by SEC in THF 
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2.3.2 Sam pie blood preparation 
Addition of CA(PEG)4 and linear PEGs to RBC samples 
To eliminate the effect of hydrophobic interactions with plasma proteins (e.g., 
albumin), the CA(PEG)4 polymers were added to washed RBCs in buffer, incubated, then 
washed again and resuspended in autologous plasma. In this protocol, plasma dilution 
was equivalent for all samples. An equivalent volume of buffer was added to aliquots 
(blood samples). 
Freshly drawn blood from three healthy human donors was anticoagulated with 
EDTA (1.5 mg/mL) and centrifuged at 1750 g for 10 minutes. The plasma was removed 
and saved, and the white buffy coat, which contains the white blood cells and plate lets, 
was discarded. The RBCs were washed three times with isotonic 10 mM Dulbecco's PBS 
(pH 7.4, 285 mOsmlkg) and spun at 1400 g for six minutes. The RBCs were resuspended 
in plasma and adjusted to a 42% hematocrit (Ht). 2 mL aliquots of blood were pipetted 
into 3 mL polypropylene containers (16 samples per donor). Stock solutions of the 
CA(PEG)4 polymers and PEG standards listed in Table 2.2 were prepared in PBS (10 
mM) to get a concentration of 100 mg/mL. The stock pol ymer was added to each blood 
sample to get final dilutions of 1.3, 4.0, and 6.7 mg/mL with an hematocrit value of 
40.3%. 
Addition oflinear reactive PEG (mPEG-SPA) to RBC samples 
Freshly drawn human blood was anticoagulated with EDT A and centrifuged at 
1750 g x 10 minutes. The plasma was removed and saved, and the buffy coat aspirated. 
The RBCs were washed a further 3 times with PBS (2 x spins at 1400 g x 6 minutes, and 
a final spin at 1750 g x 10 minutes). Washed RBCs were resuspended to 10% Ht in 15 
mM triethanolamine buffer. An amount of 100 mg mPEG-SP A was weighed into a 50 
mL polypropylene tube. One mL of cold 10 mM HCl/saline was added to each polymer to 
dissolve it (~20 seconds). Then, 10 mL of RBCs in triethanolamine buffer were 
immediately added top each polymer sample (giving a total polymer concentration of ~9 
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mg per mL of suspension, or 100 mg per mL of packed RBCs). The samples were 
incubated at room temperature for 90 minutes. Thirty mL of PBS were added, and 
samples centrifuged at 500 g x 10 minutes. The RBCs were washed twice with PBS (500 
g x 10 minutes). RBCs were then transferred to a 3 mL polypropylene tube and 1.5 mL of 
autologous plasma added, mixed, and then centrifuged at 1400 g x 6 minutes. 
RBCs were resuspended to a 40% Ht with autologous plasma. 
Microscopy 
The morphology of the CA(PEG)4-RBCS and the control RBCs at a physiological 
pH was studied by light microscopy. For the control sample (no polymer added) and 6.67 
mg/mL samples only (highest polymer concentration), 50 ilL of blood sample was diluted 
with 250 ilL of plasma and mixed. Then, 1 drop was placed on a glass slide. A coyer slip 
was put over the sample that was allowed to stand at room temperature for 10 minutes. 
Microscopic images were recorded at 400 magnifications. 
Viscosity Measurements 
The apparent viscosity of the RBC suspensions of linear PEGs and the CA(PEG)4, 
at 25 oC, was measured over a range of shear rates (0.1-94.5 S-I) using the Contraves LS-
30 Couette viscometer (Contraves LS 30, Contraves AG, Zürich, Switzerland). The 
Contraves LS-30 rheometer is a Couette concentric-cylinder viscometer operated at a 
constant shear rate and equipped with a thermostated sample bath. 
Myrenne aggregometer 
RBC aggregation was quantified using a photometric Rheoscope (Model MA-1 
Aggregometer, Myrenne GmbH, Roentgen, Germany) interfaced with a computer.6 Stasis 
and very low shear conditions were produced using a transparent cone-plate geometry. 
This method employs the light transmission of Schmid-Schonbein et al. 104 The blood 
sample is placed in a photocell which is perpendicular to the light source. The principle of 
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this technique is based upon the increase of light transmission through a RBC 
suspension, which occurs when individual cclI aggregates into rouleaux; gaps in the 
suspending medium between the aggregates allow more light to pass through the RBC 
suspension. The Myrenne aggregation parameter M, is obtained by first shearing the 
sample at a high shear rate (600 S-I) to assure rouleaux disruption and RBC orientation 
with the flow. After abrupt cessation of the rotation, the variation of the light transmission 
is recorded for 10 seconds, the average change in the light transmission over this period is 
taken as the M value (arbitrary units). If no aggregation takes place, then the light 
transmission does not change and M = O. The rouleaux formation process reduces the 
light scattering and allows for more light to pass through the photocelI, resulting in a 
positive M value, for which the magnitude increases with the extent of aggregation. 
Therefore, an increase in either M (stasis) or Ml (at 3 S-I) indicates enhanced RBC 
aggregation. Note that M thus reflects aggregation in the absence of shear and Ml reflects 
aggregation when fluid movement tends to promote celI-celI interaction and both M and 
Ml increase with increasing RBC aggregation.6 For this study, a normalized Myrenne 
aggregation data (M and Ml) were determined by dividing the M values of the test 
samples by the M values of the RBCs with no polymers added (control sample). M index 
greater than unity reflect RBC aggregation. Aggregation measurements for aH samples, 
Myrenne M and Ml values were recorded in duplicate per donor. 
2.4 Statistical Methods 
Data are presented as mean ± standard deviation (SD). Comparisons between data 
groups were carried out pair-wise using ANOV A with the Bonferroni test using the data 
software OriginPro 8 (OriginLab, MA, USA). Associations between variables were 
assessed by least-squares linear regression. 
CHAPTER 3: CHARACTERIZATION OF THE STAR-
SHAPED CA(PEG)4 POLYMERS 
3.1 Preparation of the ChoUe Acid Derivatives and CA(PEG)4 
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The synthetic route of the cholic acid derivatives and CA(pEG)4 polymers are 
shown in Figure 2.2 and listed in Table 2.1. The first step consists of the esterification of 
the carboxylic acid group at position C24 of CA to an ester group. This reaction has been 
reproduced several times and resulted in high yield (>90%) and the NMR spectrum of 
compound CAME is provided in Figure 3.3. 
The second step invoives the preparation of the compound CA-NHCB2CB20B 
via the nucleophilic acyl substitution reaction of the ester group of CAME and 
aminoethanoL In this reaction, the nucleophilic amine attacks the electrophilic carbon of 
the ester and the nucleophilicity of the amine is dependent on its lone pair. If acid was 
added, the basic amine would get protonated and the Ione pair would become unavailable 
for nucleophilic attack. The reaction would not be favored thus heating is used to drive 
the reaction forward. The mechanism is illustrated in Figure 3.1. 
R=CA 
R' = CH3 
+ 
Figure 3.1. Mechanism of nucleophilic acyl substitution 
H-o--R' 
In this mechanism, the stronger base (amine) is used and the weaker base (methanol) is 
produced. AIso, before the alcohol (leaving group) portion of the ester departs, it picks up 
an Ir so that it can leave as the weak base alcohol (R'OH) rather than as the strong base 
alkoxide ion (R'O} This is because weaker bases make better leaving groups. 
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The precursor CA-NHCH2CH20H with four alcohol groups was used as a 
multifunctional alkoxide macroinitiator for the AROP of EO. The macroinitiator was 
prepared by a partial deprotonation by reacting with a solution of naphthalene potassium 
in THF. The macroinitiator reacted with naphthalene potassium to completion at room 
temperature which was evident by the stable green color that slowly disappeared when all 
the hydroxide groups had been reacted. However, in sorne cases the green color 
disappeared too quickly probably due to moisture content which impeded the 
polymerization process. 
In a "core-first" approach with the multifunctional alkoxide macroinitiator, there 
is a high tendency of strong aggregation of the propagating alkoxides which usually leads 
to poor solubility, hence resulting in poor molar mass control and broad molar mass 
distributions. lOo Therefore, the extent of the deprotonation of the macroinitiator was 
restricted to 25% in most cases. Under such homogenous conditions, the exchange of 
protons between dormant hydroxyl groups and active alkoxides were rapid enough to 
generate a dynamic equilibrium as shown in Figure 3.2. 
In this case, the extent of aggregation is limited because the rate of exchange (Rex) 
is rapid with respect to the rate of propagation (Rp). This implies that the synthesis of 
PEO chains under controlled conditions from precursor CA-NHCH2CH20H and the 
predictable molar masses with narrow molar mass distribution can normally be achieved. 
These conditions worked well for low molar mass CA(PEG)4 polymers but proved to be 
problematical for generating higher molar masses in a predictable manner. For polymers 
of molar mass greater than 10 000 glmol, the EO had to be in excess. For example to 
synthesize the CA(PEG)4 with 15000 glmol, an excess of equivalent EO for a molar mass 
of 20 000 glmol had to be used in order to get the desired molar mass. Prior to the 
addition of EO, the reactor vessel was cooled in a dry-ice acetone bath. Perhaps, during 
the slow heating to 40 oC, sorne of the EO may have evaporated. 
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+ 
propllgating specie.s dormant species 
Figure 3.2. Exchange of protons between dormant hydroxyls and active alkoxide 
species is fast during the anionic ring opening polymerization (AROP) of ethylene 
oxide (EO) where the rate of exchange (Rex) is much higher than the rate of 
propagation (Rp) or Rex> > Rp Reproduced from ref 105. 
Anionic ring-opening polymerization (AROP) of ethylene oxide required a reactive 
initiator, naphthalene potassium, and a polar solvent, DMSO, which were used to allow 
high solvation of cations for a fast polymerization rate. Because of the low solubility of 
the precursor CA-NHCH2CH20H and to prevent aggregation of the propagating 
alkoxides, DMSO was chosen as the solvent for the polymerization rather than THF due 
to its more dissociating properties and higher rate of propagation. 106 However, a potential 
problem associated with DMSO is the possibility of chain transfer of the propagating 
alkoxides to DMSO. Chain transfer of the growing alkoxides to DMSO gives rise to 
"dimyl" carbonions (CH3(SO)CH2) that may be capable of initiating a polymerization.107 
This implies that higher concentrations of the propagating alkoxides in the solution may 
lead to a higher probability offorming linear chains by chain transfer to DMSO. This will 
be shown in the SEC traces discussed later in the chapter. 
The production of "idealliving polymer system", where polymers with infmite1y 
high molecular weight are synthesized, is an extreme1y difficult task. The presence of 
impurities, which cannot be fully removed from the reaction mixture, and that are 
introduced with mono mer or precursor as well as with solvent, leads to side reactions. In 
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the case of AROP, active centers are mainly deactivated by reaction with electrophiles 
such as traces of water, oxygen, carbon dioxide and other impurities that cause the 
termination of the chain. Therefore, they must be rigorously excluded from the 
polymerization system. This difficulty was circumvented by changing the apparatus from 
a round bottom flask to a Schlenck flask, which limited leakage from the pressure build-
up during the polymerization. In fact, the use of the Schlenck flask led to more 
predictable high molar masses. 
This makes anionic ring-opening polymerization a very demanding technique 
(ultra purity of reagents and solvents, high vacuum, etc.), somewhat limiting applicability 
of anionically initiated polymerizations. It may take much care to avoid and reduce the 
presence of sorne termination species and sorne slow side reactions, which annihilate the 
growing ends. If the rate oftheseside reactions in the system is sufficiently slow, there is 
the possibility to achieve the desired narrow distributed polymers, with relatively high 
; 
molar masses. 
3.2 Characterization of the Star-Shaped Polymers 
The cholic acid derivatives were identified by NMR spectroscopy and the 
CA(PEG)4 polymers were characterized by NMR spectroscopy, GPC, SEC-MALS, 
MALDI-TOF, DSC, viscometer, and rheometer. 
3.2.1 NMR spectroscopy 
Proton nuclear magnetic resonance (lH NMR) spectroscopy is one of the most 
powerful techniques for elucidating the structure of chemicaI species. The identification 
of CAME was confirmedby the NMR spectrum shown in Figure 3.3(a). There is a sharp 
singlet at 3.66 ppm indicative of the methyl ester group OCH3. This is a characteristic 
feature of the methyl protons of the bile acid methyl ester. The distinguishing features of 
IH NMR spectrum of cholic acid are also present with two singlet peaks at 0.69 ppm for 
18-CH3 and 0.89 ppm for 19-CH3. The methyl proton signal of C21 is a doublet because 
its resonance is split in two due to the neighboring proton on proton signal C21. 
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Figure 3.3. IH NMR spectra of a) CAME in CDCh and b) CA-NHCH2CH20H in 
DMSO. 
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The hydroxyl group at C3 is split into a quintet due to the four protons on the 
neighboring carbons. For N equivalent, the spin nuclei splits the resonance by a nearby 
spin or group of equivalent spins into N + 1 with the intensity following the distribution 
of the Pascal's triangle. The multiplicity arises from the spin coupling between 
neighboring protons that are non-equivalent or that resonate at different frequencies. 
According to this simple multiplicity rule, the areas enclosed by the components of a 
multiplet should be the ratio of whole numbers. The overlapping resonance peaks around 
1.0-2.60 ppm are attributed to the other CH2 and CH of the steroid backbone. 
The NMR spectrum in Figure 3.3(b) confirmed the structure of the compound 
CA-HCH2CH20H by the complete disappearing of the methyl ester peak. The resonance 
peak of NCH2 at 3.08 ppm on position C25 is split into a quartet due to the three protons 
of the neighboring nucleus. The expected quartet at 3.35 ppm of CH2 of C26 is 
overlapped with the water peak of DMSO (3.3 ppm). The proton (CONH) on C24 
situated closely to the nitrogen was deshielded due to the high electronegativity of the 
nitrogen and as a result appears further downfield (7.75 ppm). The nucleus examined can 
be shield or deshield by the magnetic field of neighboring nuclei. The first order effects 
are applied when the chemical shifts of the coupled nuclei are far enough apart and the 
second order effects are applied when the chemical shifts approach one another, the 
interactions get stronger and two things occur. Firstly, the energies of the spin states shift 
and secondly, the probabilities of transitions between levels also change as a result, the 
positions and intensities of peaks will not match those predicted. 
The coupling constant, J (in Hz), is an important parameter that provides 
information about the number of different type of atoms that are close to each other in the 
molecule. It also quantifies the strength of the interaction. Coupling constants are 
independent of the strength of the applied field; therefore, it is an intrinsic property of the 
molecule. The coupling constants J were calculated by taking the peak -to-peak distance 
of each region in Hz. The protons at position C24 and C26 had the same coupling 
constant (J = 5.5 Hz) meaning that they are coupled to the same type of nucleus since 
protons are coupled if they have the same coupling constant. The NMR spectrum of 
CA(PEG)4 for the repeating unit of 7 of EO is shown in Figure 3.4. The methylene 
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protons of PEG are present around 3.4-3.5 ppm. Only a few of the cholane backbone 
chemical shifts are visible because they are smaller compared to the PEG chains. The 
other NMR spectra of the polymers can be found in Appendix 3. 
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Figure 3.4. IH NMR spectrum of a CA(PEG)4 polymer of sample 18. 
3.2.2 Thermal analysis 
DifferentiaI scanning calorimetry (DSC) was used to analyze the thermal 
properties of the CA(PEG)4 polymer samples as a function of tempe rature (see Appendix 
2). Figure 3.5 shows an evident glass transition (Tg) for sam pie 18, which has only 5 
units of ethylene oxide (EO) per chain, and it does not show any crystallization or melting 
peaks. This is probably due to the PEG chains being too short; hence, it is unable to form 
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any crystalline domain. However, when the PEG chains are too long, their 
entanglements with each other may also impede the formation of crystals. 108 
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Figure 3.5. DSC trace of CA(PEG)4 of sample 18 showing the glass transition 
temperature, Tg. 
The high molar mass of the CA(PEG)4 polymers (Sample 1 - 4) show only melting peaks 
(Figure 3.6). These uncrystallized arms might be located in the amorphous layers, and 
thus can explain the no show of the crystallization peak. The existence of globular 
structure of star-shaped PEGs could decrease the intermolecular interaction and restrict 
the macromolecular conformation, which considerably rermes the crystallization behavior 
of polymers. The thermograms in Figure 3.6 also show that the polymers were produced 
under controlled living conditions because the melting peaks are narrowed except for the 
thermogram of sample 2 which reflects bimodal characteristic since it has a slight 
shoulder near the melting peak. 
In Figure 3.7, the melting peaks were plotted as a function of the molar mass. 
Figure 3.7 shows that the melting temperature becomes slightly raised with increasing 
" l molar mass. Thus, the melting points of the polymers seem to depend on the size of the 
crystalline domains, which may be larger with increasing length of the PEG. 
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Figure 3.6. DSC traces of CA(PEG)4 polymers with different molar mass showing 
difIerent melting temperatures,Tm• 
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Figure 3.7. Relationship between the melting temperature (Tm) and the molar mass of 
the CA(PEG)4 polymers. 
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3.3 Determination of the Molar Mass Distribution 
In general, polymers do not have a single molar mass but rather have a molar mass 
distribution as they are made from chains of various lengths so that statistical techniques 
of analysis are needed to characterize them. The molar mass distribution (also known as 
the molecular weight distribution) is a term used to de scribe such a distribution (see 
Appendix 2 for details). Many properties and processing methods of polymers show a 
strong dependence on the size of the polymer chains, so that it is essential to characterize 
their dimensions. Polymers with a narrow molar màss distribution can be obtained by 
anionic polymerization or by other living polymerization techniques. In this work, the 
molar mass distributions of the polymers were determined by size exclusion 
chromatography (SEC), SEC- MALLS, and MALDI- TOF. 
3.3.1 MALDI-TOF 
MALDI-TOF mass spectrometry can provide the necessary additional molecular 
information for a large variety of pol ymer classes. It is becoming routinely used for the 
determination of the polymer molecular weight determination, copolymerization 
structure, end-group analysis, and homogeneity (see Appendix 2).109 Figure 3.8 shows a 
typical MALDI-TOF spectrum for the CA(PEG)4 polymer of sample 18. The use of 
MALDI-TOF gives irrefutable evidence of the formation of the polymers, showing 
signals of the EO repeating unit. The mass peak difference between each peak is 44.05 
Da, which equals the mass of the repeatingunit of EO. In this study, it was attempted to 
use MALDI-TOF to determine the MW of all the polymers but only the smallest molar 
mass was able to generate a good spectrum. It has been reported that mass discrimination 
for the lower mass components are favoured compared to the higher mass components 
resulting in a significantly lower average molar mass. 110 This mass discrimination effe~t 
is thought to be caused by several factors, including sample preparation, mass-dependent 
desorptionlionization, ion focusing/transmission, and mass-dependent ion detection.110 
Thus, the results are liable for lower molar mass. The MALDI-TOF results are influenced 
by the difficulty of getting higher molecular weight compounds out of the matrix support. 
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It is highly probable that the high molecular weight fractions of the polymers were 
never ionized, thus significantly lowering the molecular weight distribution. In addition, 
the success of a good MALDI-TOF spectrum also depends on the relative ratio of analyte 
to matrix. That is why we used a 2:1 and 1:1 matrix to analyte ratio but it did not make a 
difference in the results. The matrix roles are to separate analyte molecules from each 
other, absorb laser energy, and propel analyte molecules into the test chamber in the gas 
phase. If the matrix molecule concentration was less than was needed to separate all 
analyte molecules, the inter/intra molecule interaction among the an alyte molecules might 
hinder the ionizationldesorption efficiency. Furthermore, with low matrix concentration 
not enough laser energy is absorbed; both phenomena result in low signal counts. On the 
other hand, a large amount of matrix dilutes the overall analyte concentration, also 
causing low signal counts. 
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Figure 3.8. MALDI-TOF mass spectrum of CA(pEG)4 polymer of sample 18 
obtained by using a N2 laser at 337 nm wavelength with a 20 kV extraction voltage. 
Dithranol was used as the matrix in a saturated salt solution of LiCl. 
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3.3.2 SEC (size exclusion chromatography) 
Size exclusion chromatography (SEC) technique is based on the observation that 
the lower molar mass specimens are retained longer in the column because they can 
diffuse more readily in the pores of the gel. Hence, the high molar mass species come out 
ofthe column before the lower molar mass molecules. 
Sample 
1 
2 ~ 
3 
4 
5 
1 1 
15 
18 
20.00 23.00 26.00 30.0 
Retention time (min) 
Figure 3.9. SEC traces of several molar masses of CA(PEG)4 polymers in THF. 
Molar mass ofsample 1 = 19.1 kDa, sample 2 = 15.3 kDa, sample 3 = 12.6 kDa, 
sample 4 = 10.1 kDa, sample 5 = 9.5 kDa, sample 11 = 4.0 kDa, sample 15 = 2.4 
kDa, and sample 18 = 1.3 kDa. Sample details can be found in Table 3.1. Lined 
arrows indicate traces of low molar mass sampI es and dotted arrows indicate the 
presence of high molar mass. 
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Table 3.1. Molar mass of CA(PEG)4 polymers obtained by size exclusion 
chromatography (SEC) measurements in THF. 
Sample EO units Mn (glmol) Mw (glmol) PDI (X4 arms) 
106 19110 19340 1.01 
2 84 15320 16050 1.05 
3 69 12660 13 120 1.04 
4 55 10080 10600 1.05 
5 51 9500 9970 1.05 
6 40 7450 7680 1.03 
7 39 7320 7616 1.05 
8 32 6020 6840 1.14 
9 26 5080 6420 1.20 
10 25 4850 6490 1.33 
11 20 4404 4230 1.04 
12 17 3470 3570 1.05 
13 16 3420 3580 1.04 
14 15 3 160 3350 1.11 
15 11 2380 2540 1.07 
.16 8 1850 1930 1.05 
17 7 1640 1 760 1.07 
18 5 1330 1360 1.02 
Traces of low molar mass fractions were observed for the higher molar mass polymers 
(samples 2, 3, 4 and 5) shown in Figure 3.9 and are indicated by a lined arrow. This 
could be related to a small extent of incomplete anionic ring-opening polymerization 
initiation resulting in fewer arms, or a small extent of chain-transfer reactions resulting in 
sorne smaller arms and sorne linear chains. These low molar mass fractions could not be 
separated by solvent extraction which led to a slight broadening of the molar mass 
distribution. 
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The amount of the initiator needed for the polymerization was small because 
only 25% deprotonation was required, III therefore, it was hard to measure the precise 
amount of initiator due to the imprecision of measurements of volumes smaller than 1 
mL. Thus, the excess amount of initiator may have activated the polymerization of sorne 
linear PEG chains. Another possible way to explain the presence of small linear PEG 
chains in the SEC traces is from the distillation of the EO in tert-butyl lithium in hexane 
solution. In the final preparation, the EO is distilled out of the tert-butyl lithium solution 
in hexane by warming the round bottom flask to condense the EO vapors into the 
graduated cylinder, which is being cooled in a dry-ice acetone bath. If the temperature 
was too high, the tert-butyllithium might have initiated the polymerization of sorne linear 
PEGchains. 
As also seen in Figure 3.9, the SEC traces show the presence ofhigh molar mass 
fractions especially for samples 1 and 5, which is indicated by a dotted arrow. This could 
be related to the formation of aggregates. The low molar mass sample 18 shows a low 
molar mass tail in the otherwise narrowing peak at the highest Mn = 1.3 kDa (Figure 3.9 
and Table 3.1), which can indicate slow propagation of a fraction of the chains.14 This 
can be due to non-uniform concentrations at the gas-liquid interface, resulting from 
ineffective mixing in the highly viscous reaction system at these molar masses. 
In general, the SEC is a good method to determine the molar mass of polymers. 
The results greatly depend on structural resemblance of the standards, which are used to 
make the calibration curve, to that of the pol ymer being analyzed. In SEC measurements, 
the pol ymer molecules are fractionated according to the hydrodynamic volume. The size 
of star pol ymer molecules is known to be smaller than that of linear ones having the same 
molar mass.112 Therefore, the SEC method underestimates the molar mass of the star 
polymers due to their compact volumes compared to linear polymers. 
Moreover, amphiphilic macromolecules, which contain segments of with very 
different polar properties, have their distribution of the chemical composition change with 
the overall interactions with the solvent, thus, disturbing the relationship between the 
hydrodynamic volume and the molar mass. Therefore, the true molar mass cannot be 
obtained using SEC alone. 
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The addition of a multiangle laser light scattering detector (MALLS) to SEC 
enabled molar mass to be determined absolutely and independently of any calibration or 
reference standards from each slice of the polymer fraction (see Appendix 2). The 
precision of this method requires that the concentration of each eluting fraction be known 
as well as the specific differential refractive index increment, dnlde. The dnlde describes 
the change of the refractive index of a polymer solution relative to the change of the 
polymer concentration. The dnlde value depends on the polymer composition, solvent, 
and wavelength. 113 The determination of dnlde is done using one of the two following 
methods described below. The online method allows the calculation of the dnlde from the 
peak of the injected sample of known concentration and volume. It also assumes that 
100% of the injected polymer elutes from the column. On the other hand, the offline 
method calculates the dnlde from a slope obtained by preparing several known 
concentrations using the differential refractive (DR!) detector with the following 
equation: 
dn I1n=-xe 
de 
(3.1) 
where I1n is the differential refractive index and e is the concentration of the sample. Such 
an example is shown in Figure 3.10 where the dnlde was measured offline and gave the 
same values as the dnlde measured online. Therefore, for several of the polymers studied, 
the dnlde online was sufficient for the calculations of the molar mass. 
The SEC-MALLS technique assumes that the molar mass of each elution slice 
contains molecules of a single molar mass, or at least a very narrow distribution. The 
molar mass for each slice is calculated according to the Zimm and Stockmayer 
equation: 112 
Re = MP(0) _ 2A2eM 2 p 2 (0) + ... K*e (3.2) 
where Re is the excess Rayleigh ratio; K* is a constant; e is the solute concentration 
(g/mol); M is the weight-average molar mass; pre) is the form factor or "scattering 
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function" and approximately equal to 1-2J.1?(r2 )/3!+ ... , where 1l=(41t/À)sin(9/2), and 
(r 2 ) is the mean square radius; and A2 is the second virial coefficient (mL molli). For 
vertically polarized incident light with a wavelength Â.o in vacuum, K* is denoted by: 113 
(3.3) 
where nois the refractive index of the solvent, NA is the Avogadro's number, and dn/dc is 
the specifie refractive index increment. 
A 
~ 
ë 
~ 
" B< 
" 0 4· 
~ 
~ 
" ~ 2· 
0.0 
:: 
~ . ;: 
"U J "u J n~ 
20.0 40.0 50.0 60.0 70.0 1Il.0 
time(min) 
>< B u 
~ 
.E 
u ;. 
"fi 
.E 
!! 
(i3 
.~ 5 
~ 
Ci 
O.[UI) 0.CDJ2 n fTTl.4 n rnv:; n nim nm10 0.0012 
Concentration (gImL) 
Figure 3.10. Detennination of dn/dc oftline of sample 13 (3.4 kDa) of CA(PEG)4 polymer 
in water. (A) shows the area selected of the differential refractive index data and (B) shows 
the slope of the resulting RI data. dnldc oftline = 0.1412 ± 0004 mLig and dn/dc online gave 
0.1417 mL/go 
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The concentration of the polymer is measured for each elution slice using a 
refractive index detector. A plot of RéI(K*c) or (K*c)/R(8) as a function of sin2(8) is 
constructed at each retention time to give M and the root mean square (RMS) radius 
distribution. These plots are commonly referred to as Debye and Zimm plots respectively. 
M can be determined from the intercept at zero angle whereas the slope yields the mean 
square radius. 1 13 The second virial coefficient, A2' is essentially zero if the concentration 
is sufficiently small (Az cO). When A2 0, the Equation 3.2 can he simplified to give: 
(3.4) 
and 
( 2) 112 ~ 3 À,o r:::-;:; r =--...;moM 
41l1lo 
(3.5) 
After the concentration, molar mass, and mean square radius have been 
determined for each slice, the molar mass and the square radius can be calculated. The 
radii of the star-shaped polymers are not shown here due to the large errors in their 
estimations. This is because the size of the polymer molecules in the solution is small 
enough such that the particle scattering function Pre) becomes ~ty and the scattered 
light is no longer angular dependant. Therefore, no meaningful Rg values could be 
obtained. Also the resolution limitations of the instrument are dependant on the 
wavelength ofthe laser which is 690 Dm. The minimum reliable size that can be measured 
with the instrument is 10 Dm and the size of the CA(PEG)4 polymers are smaller than 2 
Dm, which will be discussed later. 
Molar mass obtained with SEC-MALLS for the CA(PEG)4 polymers in water and 
in phosphate buffer saline (PBS) solution are given in Table 3.2. Note that Table 3.2 
shows data for the weight average of the molar mass (Mw). Marked differences are 
observed for the polydispersity index (PDI) and Mw obtained with SEC only and SEC 
coupled with MALLS. This is due to the occurrence of peak broadening observed with 
SEC, which caused each elution slice to contain a non-monodisperse mixture. As a result 
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of this effect, SEC with MALLS has a tendency to overestimate the n average 
molecular weight, in spite of these broadening effects; we may in practice still make the 
assumption that each slice is monodisperse (only one molar mass is present).ll3 There is 
no obvious difference between the Mw obtained in water and in PBS except that the molar 
mass obtained in PBS appeared slightly larger. Although SEC-MALLS is an absolute 
method, the changes in the composition of the amphiphilic polymer also alter the dnldc, 
which may cause errors in the measured molar mass.114 Therefore, great caution has to be 
exercised when interpreting the molar mass data for the amphiphilic star polymers. 
Table 3.2. Molecular weights for CA(PEG)4 polymers in water and PBS obtained by 
conventional SEC and SEC-MALLS measurements. 
Sample SEC SECIMALLS 
THF Water PBS 
Mw (g/mol) PDI Mw (g/mol) PDI Mw (g/mol) PDI 
1 19340 1.01 22540 1.12 28130 1.47 
2 16050 1.05 21500 1.22 20370 1.32 
3 13 120 1.04 13890 1.11 15840 1.30 
4 10600 1.05 13 800 1.04 ·13430 1.25 
5 9970 1.05 9980 1.05 10460 1.07 
6 7680 1.03 8100 1.18 8730 1.15 
7 7616 1.05 10300 1.91 10360 1.07 
8 6840 1.14 6130 1.24 7410 1.21 
11 4230 1.04 4840 1.05 5780 1.04 
12 3570 1.05 4240 1.03 5930 1.06 
13 3580 1.04 4630 1.09 5500 1.08 
SEC in THF data are taken from Table 3.1 
Examples of molar mass distributions for the CA(pEG)4 star-shaped polymers are 
given in Figure 3.11. A small peak is observed in the high molecular weight distribution 
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especially when water was used as the solvent. This is probably due to sorne 
aggregation of the PEG polymers in water. As mentioned in Section 2.2, a concentration 
of about 10 mg/mL was used to dissolve the polymers. Such a high concentration was 
necessary in order to achieve a decent detector signal. The aggregates were greatly 
reduced when a salt solution of PBS was used (Figure 3.11.b) A bimodality distribution 
was observed for the high molar mass polymer sam pIe 1, which is indicative of non-
controlled anionic polymerization as discussed in the preparation method. 
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Figure 3.11. SEC-MALLS chromatogram of star shaped-polymers CA(PEG)4 a) in 
water and b) in phosphate buffer saline solution (PBS). Sample 1 = 19.1 kDa; 
sample 2 = 15.3 kDa; sample 3 = 12.6 kDa; and sample 4 = 10.1 kDa. 
In general, the molar masses obtained from SEC-MALLS are higher and have a 
greater PDI than in SEC with THF as the eluent. The SEC-MALLS is not without its 
limitation for the determination of molar mass of the polymers. First, the SEC-MALLS 
method cannot quantify low molar mass polymers below a few thousands kDa. This 
arises due to the uncertainty of measured radius of gyration (Rg) values increasing rapidly 
as the size of the polymers approaches the cut-off molar mass at which the angular 
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dependence of the scattered light disappears. Theoretically, light scattering can detect 
sizes down to about a 20th of the incident wavelength.1l5 In addition, for a given 
concentration (c), the scattered light signal (l) is proportional to the molar mass, (M) and 
dnldc: 
(dn)2 1 scallered oc Me de (3.6) 
This implies that for low M, relatively high concentrations are required to produce 
detectable light scattering signal. However, in practice the concentrations of low M 
polymers cannot meet the SIN requirement. If the concentration were high, the viscosities 
of the polymer solution would be too high to obtain good quality chromatograms, which 
would result in column overloading and flow problems causing poor detection limit, or 
high errors for the Rg at the low M 
Since SEC alone requires a calibration curve to determine the molar mass, it is 
considered as a relative method. However, SEC alone can provide a rapid and good 
estimation of molar mass when the other characterization instruments are not available. 
Absolute molar mass determination is possible when MALLS is combined to SEC or with 
MALDI-TOF. However, as mentioned above, MALDI-TOF is more sensitive for lower 
molar mass polymers whereas SEC-MALLS is not. Therefore for the determination of the 
distribution of the lower molar mass, MALDI-TOF is preferable and for higher molar 
mass, SEC-MALLS is better. 
Determination of the Number of Arms 
The Zimm-Stockmayer approach 112 was employed to determine the number of 
arms or branching ratio in the CA(pEG)4 star-shaped polymers. As discussed above,in 
SEC-MALLS both the M and Rg are measured simultaneously at each elution slice of a 
chromatogram. For example, sample 8 was used to determine the number of arms in the 
polymer. The SEC chromatograms as a function of the elution volume of the linear PEG 
and sample 8 of the star-shaped CA(PEG)4 polymers in water are shown in Figure 3.12. 
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Information about the branching ratio can be obtained by two methods. The 
first method consists of plotting the Rg against the molar mass (conformation plot) and in 
the second method, the molar mass is plotted against the elution volume. Since the Rg 
values were outside the limit of the instrument as mentioned above, the mass method was 
used to determine the number of arms. The mass method compares molar masses at equal 
elution volumes and requires overlapping of the linear and the branch plot (Figure 3.13). 
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Figure 3.12. An overlay of molar mass distribution as a function of the elution 
volume at 90° light scattering for the linear PEG and sample 8 of the star-shaped 
CA(pEGk The two vertical lines delimit the overlapping region of the elution 
volume of the two polymers. 
Figure 3.13 shows that both the linear and the star-shaped sample had abnormal 
SEC elution behaviour: the star-shaped curves up at low elution volumes and for the 
linear PEG, the plot curves back up at high elution volumes rather than the normallinear 
decrease with increasing elution volume. The curvature is usually typical of highly 
branched polymers. IIS However, in our case the curvature was much more pronounced for 
the linear sample. This may be due to the nonsize exclusion mechanisms (e.g. adsorption) 
that can delay sorne molecules. Due to this effect, the slices of higher elution volume can 
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contain a mixture of molecules of lower molar mass and molecules of higher molar 
mass that were retained by the nonsize exclusion mechanisms, which is frequent in 
aqueous SEC. \03 AIso, the curves strongly deviate at low elution volumes. This deviation 
is due to the presence of branching. Branched molecules are more compact than linear 
ones and therefore they have smaller sizes when molar mass are equal. The retardation of 
the large molecules in the size exclusion separation reflects the molecular architecture of 
branched molecules, though the origin of the retardation remains unclear.116 The delay in 
the size exclusion separation may be due to mechanical entanglements in the column 
packing and their later elution with smaller molecules.1l7 
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Figure 3.13. The molar mass overlap between the linear PEG (0) and star-shaped 
CA(PEG)4 (0) at each elution volume using the data selected from the region defined 
by the two verticallines in Figure 3.12. 
In order to determine the number of arms for the star-shaped polymers, the 
branching ratio (gM) must be determined first. The branching ratio (gM) equals unity for 
linear polymers and decreases with increasing number of branches. 
The gM can be calculated from: 
M lin gM = --( J
(I+a)/e 
M br V 
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(3.7) 
where Mlin and Mbr are the molar mass of linear and branched polymers, respectively, a is 
the Mark-Houwink exponent for the linear polymer, and e is the draining parameter 
ranging from 0.5 to 1.5. The draining parameter e is generally unknown and changes with 
the mol~ mass.1l6 The ratio of the molar masses is taken at the same elution volume V 
and is calculated for all volume slices of the overlapping region as shown in Figure 3.12. 
The branching ratio for star-shaped CA(PEG)4 polymers is shown in Figure 3.14 where 
typically for PEG polymers a = 0.712 and e =1.1l8. Figure 3.14 shows that the gM is 
lower than unit y meaning that there is branching in the polymer. 
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Figure 3.14. Branching ratio versus molar mass for sample 8 of the star-shaped 
CA(PEG)4 polymer calculated by the mass method using a = 0.712 and e = 1 In 
Equation 3.7. 
A fundamental model for the determination of branching has been derived by 
Zimm and Stockmayer. 112 It can be used for the determination of the number of arms in a 
polymer from molecular weight and Rg data obtained from SEC-MALLS. The branching 
68 
ratio, gM, is related to the average number of branching units or arms per molecule for 
star polymers with monodisperse arms of equallength linked together by 
3f-2 
gM = f2 (3.8) 
where / is the number of arms. The model would be appropriate for star molecules 
produced under controlled anionic polymerization conditions where the chains emanate 
from a central core.1l9 For Eq. 3.8, the left hand side gM is known already (see Figure 
3.14). The equation is solved for/for each slice which produced a reasonable value of gM. 
Note that if gM falls outside of 0 to 1, no value of twill be calculated for that slice. Note 
that when gM equals unity it signifies no branching, whereas values lower than unit y 
signifies that there is branching in the sample. The Astra software generated the 
corresponding data shown in Figure 3.15. By simply finding the molar mass of the 
branched samp1e that was used, in this case sample 8 (6 130 Da), and tracing a line unto 
the y-axis, the number of arms can be determined, and was found to be four (Figure 
3.15). Therefore, sample 8 shows branching character and the star-shaped polymer most 
likely has four arms. 
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Figure 3.15. Determination of the number of arms for a star-shaped CA(PEG)4 
polymer of sample 8 ( 6 130 Da). The number of arms if = 4) is determined by 
tracing a line from 6 130 Da to the y-axis. 
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The determination of the number of arms by using the mass technique is not 
without its own limitations. The equation assumed that the polymers have the same 
hydrodynamic volume, when we know that star-shaped polymers are more compacted 
than linear polymers of the same type. What Figure 3.15 does show is the presence of 
branching in the polymer and provides a good estimation of the number of arms that is 
present in the polymer. 
3.4 Determination of the Hydrodynamic Radius, Rh 
Star shaped polymers recently attract increasing interest due to their compact 
structures, which may lead to peculiar rheological properties. This is of particular interest 
for the modification of the RBC rheology. The influence of the size in aqueous 
environment of a macromolecule on RBC aggregation is an important factor to consider 
and may be even more important than the specific type of macromolecule.6 As it was 
mentioned in the introduction, Armstrong et al. showed that macromolecules including 
non-ionic polymers and plasma proteins with a hydrodynamic radius (Rh) smaller than 4 
nm were able to inhibit RBC aggregation, whereas those with Rh greater than 4 nm 
promoted RBC aggregation.6 The Rh of the individual samples of the CA(PEG)4 star-
shaped polymers were calculated from their intrinsic viscosities using the Einstein 
viscosity relation. 
Polymer concentrations of 1, 3, 5, 7, 13, 17, and 23 mmol were prepared by 
adding an appropriate amount of pol ymer in doubled distilled water. AlI solutions were 
clear and without evidence of precipitation. The viscosities (1'/) of the solutions were 
measured at 25 oC using a viscometer. The specific viscosity (l'/sp) is the fractional change 
in viscosity upon addition of polymer and is defmed as 
(3.9) 
where 1'/ and 1'/0 are the viscosities of the solution and of the solvent, respectively. To 
eliminate the effects of intermolecular interference on viscosity, it is necessary to 
extrapolate to infinite dilution. The intrinsic viscosity [1'/] (mL/g) of the polymers 
solutions were determined by extrapolation of 'lsp divided by the concentration (c) 
versus the concentration to infinite dilution: 
(3.10) 
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Both (17s!C) and (l/c)ln(17/'lo) showed reasonably good linear dependence on the 
concentration expressed in ml/g . An example for sample 4 is shown in Figure 3.16. 
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Figure 3.16. Determination of the intrinsic viscosity of the star-shaped CA(PEG)4 polymer 
in water at 25 oC for sample 4 with a molar mass of 10.1 kDa. 
The hydrodynamic radius (Rh) of the polymers were determined by usmg a 
previously published method.6 Rh was assessed according to Einstein viscosity relation, 
modeling the hydrated polymer molecules in terms of equivalent hydrodynamic spheres 
that wou Id increase the viscosity to the same extent as solid spherical particles of volume 
Ve: 
[17] = 2.5NVe 
M 
(3.11 ) 
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where Mis the molecular weight of the polymer in glmol, N is the Avogadro's number, 
and Ve is the volume of an equivalent spherical particle. Since Ve= -î xRh3, rearrangement 
of Equation 3.11 gives: 
(3.12) 
The values of the Rh and the [tl] of the samples are listed in Table 3.3 and are 
illustrated in Figure 3.17. The CA(PEG)4 polymers in water have a compact structure 
with a Rh value less than 2 nm and a low intrinsic viscosity. The viscosity effect depends 
on the temperature, the nature of the solvent and polymer, the polymer concentration, and 
the size and shape of the macromolecules. Typically, the viscosity of a solution increases 
as the molar mass of the macromolecules increases. Figure 3.17 shows a linear increase 
of the [tl] and Rh with increasing molar mass, however, at high molar mass (~15 kDa), the 
[tl] starts to increase much more rapidly than the Rh. The plot of [tl] shown in Figure 3.17, 
consists of two distinct linear regions. The second region has a relative slope value of 
approximately 1.8 to that of the first region. The differences between these two regions 
can be explained in terms of two competitive effects in polymer solutions: free volume 
and entanglements.120 A polymer with shorter chains has more space to move freely, thus 
it has less chain entanglements. Therefore its viscosity is defmed primarily by its free 
volume, while a polymer with longer chains has more chain entanglements and less 
movement. This means that its viscosity is defined mostly by chain entanglements than 
free volume effects. This is a common behavior for a wide range of polymers. 120 
In a polymer solution, because the solvent is inside the polymer coils, it cannot 
attain the velocities it would have in the absence of the pol ymer. These random coils can 
be perceived in the Einstein's equations (Eq. 3.12). Thus, the intrinsic viscosity method 
assumes that the radius of the spheres is constant, while in reality the shape of the 
polymer coil continuously changes as the polymer segments are in constant motion. From 
Equation 3.12, the intrinsic viscosity depends on the molar mass and this relationship is 
usually expressed with the Mark-Houwink equation: 
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(3.13) 
where M represents the viscosity average-molar mass, and K and a are Mark-Houwink 
constants. These constants depend upon the polymer andsolvent. The molar mass of the 
polymers were not determined by this method because it has been determined by more 
reliable methods such as SEC-MALLS, consequently, it was only used to determine the 
hydrodynamic radius. 
Table 3.3. Experimental results and equivalent sphere hydrodynamic radius for the star-
shaped CA(PEG)4 polymers in doubled distilled water. 
Intrinsic 
Mw Mn Hydrodynamic 
Sample 
(g/mol) (g/mol) 
viscosity [17] ± Ôb 
radius Rh ±Ôh (nm) 
(g/mL) 
1 22540 20130 2.26± 0.89 1.90 ± 0.76 
2 21500 17580 1.81 ± 0.70 1.64 ± 0.63 
3 15350 13 890 1.21 ± 0.]6 1.34 ± 0.14 
4 13 800 12300 1.06 ± 0.23 1.18 ± 0.66 
11 4840 4620 0.35 ± 0.09 0.62 ± 0.17 
15 2540 2380 0.13 ± 0.12 0.38 ± 0.13 
]8 1360 1330 0.04 ± 0.11 0.20 ± 0.12 
Mw is average molar mass determined by size exclusion chromatography coupled to 
multi-angle laser light scattering (SEC-MALLS) in water 
Mn is the number-average molar mass determined by SEC-MALLS in water 
.1b is the confidence limits for the intercept b for the linear regressiony = mx+b for N = 
5 at 95% confidence interval 
.1h is the standard deviation of~. 
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Figure 3.17. Intrinsic viscosity [11] (0) and hydrodynamic radius (Rh) (0) against the 
average-number molar mass (Mn) for a series of solutions of CA(PEG)4 polymers in 
water at 25 oC. 
3.5 Rheology Study of the Star-Shaped Polymers 
The small size of the star-shaped CA(PEG)4 polymers and branching character 
can lead to unique properties. These polymers are compact and have high segment 
density, which is unobtainable by most other types of polymers. Sorne of their unique 
properties are lower crystallinity, and lower solution viscosity than those of 
corresponding linear polymers. Most importantly of interest for this study are their 
solution viscosity properties as they pertain to the modification of red blood cell (RBC) 
aggregation. 
The concentration dependence on the flow curves is shown in Figure 3.18 for 
sam pie 1 (19.1 kDa) in water. Below the concentration of 0.3% (w/v) there was no 
significant difference between water and the polymer solutions. Beyond 0.3%, there was 
a significance among flow curves with P < 0.05 and the viscosity increased as the 
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concentration increased. The increase of pol ymer concentration in water results in more 
frequent contacts between the macromoJecules and the formation of chain 
entanglements. [9 
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Figure 3.18. Semi log scale plot of the concentration dependence on the flow curves 
of star-shaped CA(PEG)4 polymer of sample 1 in water with a molar mass of 19.1 
kDa at 25 oC. A significant difference was found for concentrations above 0.1 % for 
multiple pair-wise comparisons with P < 0.05 using Anova test. 
The molar mass dependence on the flow curves of the CA(PEG)4 polymers at 
0.3% (w/v) in water is depicted in Figure 3.19. Shear thinning occurred at low shear rates 
for the star-shaped polymers. Under the action of shear stress, the polymers align, orient, 
and disentangle themselves in order to flow more easily. The highest molar mass 19.1 k 
Da exhibits the highest apparent viscosity around 0.001 Pa.s and the lowest molar mass 
exhibits the lowest apparent viscosity around 0.00095 Pa.s. However, under shear rate, 
the normal increase in the apparent viscosity with the molar mass is not observed for the 
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molar mass 10 kDa, which shows lower apparent viscosities than the 4 kDa and the 15 
kDa, which shows lower apparent viscosities than the 12 kDa. These inconsistent 
behaviors may be due to the fact that star polymers consisting of shorter arms, have chain 
stiffness and greater interaction with the core, which can cause competiting effects. 121 
Though, it was shown that the star polymer had branched architectures, it is also possible 
that the length of each arm or the degree of polymerization is not equal for each arm. 
These possibilities could account for the unpredictab1e behavior of the molar mass effect. 
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Figure 3.19. Semi log scale plot of the molar mass dependence on the flow curves 
for star-shaped CA(PEG)4 polymer in water at 25 oC. A significant difference was 
found for multiple pair-wise comparisons with P < 0.05 for Anova test. 
The viscosity profiles of different molar mass of the star-shaped polymers were 
also studied in phosphate buffer solution (PBS) at a concentration of 0.3 % (w/v). PBS is 
a buffer saline solution that is commonly used in biological applications because the 
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osmolarity and ion concentrations of the solution usually match that of human blood.122 
Figure 3.20 shows pronounced shear thinning behavior for aIl polymers at 25 and 37 oC. 
This shear-thinning viscosity behavior results from the coil-like behavior of most polymer 
fluids. 120 Under shear, the coils rotate causing disentanglementlentanglement with their 
neighbors. This means high apparent viscosity at low shear rate. As the shear rate 
increases, the coils rotate too fast to re-entangle, so the apparent viscosity decreases. 
Figure 3.20 also shows that there is no molar mass effect at the 0.3% (w/v) concentration 
for the star polymers in PBS and that there is no significant difference between the 
viscosity profiles at 25 and 37 oC with P > 0.05. 
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Figure 3.20. Shear thinning behavior of the viscosity profiles of CA(PEG)4 polymers 
in phosphate buffer saline solution (PBS) at 0.3% (w/v) (A) at 25 oC and (D) at 37 
oC. No significance difference was found at 25 and 37 oC for multiple pair wise 
comparisons (P > 0.05, Anova). 
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The presence of salts or ions in solution usually disrupts the hydrogen bonding 
or the ordered arrangement of the water structures along the PEO chains which should in 
practice decrease the viscosity.123 However, the viscosities of the polymers in PBS are 
remarkably greater compared to the CA(PEG)4 solutions in pure water. This suggests a 
more complex arrangement of the polymers in saline solutions. Clearly, this reveals that 
CA(PEG)4 in solution possesses interesting rheologica1 properties that merit more in 
depth studies. 
In summary, the rheological results showed that the CA(pEG)4 in solution exhibit 
pronounced shear thinning behaviour especially for high molar mass fraction and that the 
viscosity was considerably higher in PBS solution than in water. 
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CHAPTER 4: BLOOD EXPERIMENTS 
The effect of the star-shaped CA(PEG)4 polymers on RBC aggregation and 
viscosity were compared to linear PEGs by the following techniques: a rheometer was 
utilized to measure the effect of the pol ymer samples on blood viscosity at varying shear 
rates; a laser aggregometer was used to quantify the extent of RBC aggregation by 
measuring the rate of change of light transmission through a sheared blood sample; and 
light microscopy was used to evaluate the normal morphology (e.g. biconcave discs) of 
the treated RBCs. The results of the star-shaped polymers will be presented [IfSt and then 
compared to linear PEGs and to the activated PEG. 
4.1 Effeet ofstar-shaped CA(PEGs)4on human RBCs 
4.1.1 Viseosity profiles of RBC samples with CA(PEG)4 
The molar mass effect on blood viscosity was evaluated at various shearing rates 
and is shown in Figure 4.1. The control sample (i.e. no polymer added) and all the 
polymer samples show increased blood viscosity with decreasing shear rate. This is 
indicative of normal RBC aggregation formation, which occurs at low shear rates. The 
viscosity profile data were not significantly different at a concentration of 6.6 mg/mL 
(polymers in PBS, P > 0.05). Therefore, no obvious molar mass effect was detected. 
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Figure 4.1 Viscosity-shear rate data of RBCs suspended in autologous plasma at 
25°C with CA(PEG)4 solution (6.6 mg/mL). AU flow curves show typical non-
Newtonian behavior for an aggregating system, the increase in viscosity with 
decreasing shear rate is indicative of RBC aggregation. Data are presented as mean ± 
standard deviation (S.D.). Data showed no significant difference with P > 0.05. 
Another way to extrapolate more information from the viscosity profiles plotted in Figure 
4.1 is to plot a bar graph of the apparent viscosity as a function of the ratio of the low 
shear rate to the high shear rate (0.15 S·I/ 94 S·l). Such graph is depicted in Figure 4.2. 
Although a reduction of blood viscosity for the CA(PEG)4 samples is observed when 
compared to the control (no polymer added), especially for the 10 k:Da and 12 k:Da, it was 
found not to be significant (P > 0.05). The rheometer is probably not sensitive enough to 
detect the inhibition ofRBC aggregation. 
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Figure 4.2. Apparent viscosity ratio (0.15 S-1 / 94 S-I) of RBCs suspended in 
autologous plasma at 25°C with a CA(PEG)4 at a pol ymer concentration of 6.67 
mg/mL for n = 3 . Data are obtained from Figure 4.1. 
There are several reasons which can account for significant variability when 
comparing the aggregability of RBCs from healthy donors. As aforementioned, RBC 
aggregability varies from individuals with different age and gender groups. When 
suspended in the same aggregating medium, different human donors can show up to two-
fold variation in their aggregability.6 In this study, the subjects were two males and one 
female from different age groups. Even within the same individuals, there can be sorne 
differences in the aggregability of RBCs because older RBCs tend to show greater 
aggregability compared to younger ones. 124 
4.1.2 Myrenne aggregation data of RBC samples witb CA(PEG)4 
The effects of the molar mass of CA(PEG) on the Myrenne aggregation indices 
(M (stasis) and Ml (at 3 S-I)) of RBCs suspended in plasma were evaluated by adding a 
predetermined amount of pol ymer concentrations of 1.33, 4.0, and 6.7 mg/mL. The 
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resulting data are shown in Figure 4.3 and are presented as relative values to that of the 
control (i.e. buffer added without polymer). In that manner, the influence due to simple 
dilution effects is eliminated. Relative aggregation values less than unit y indicate reduced 
aggregation. The results clearly demonstrate that at a concentration of 4.0 and 6.7 mg/mL, 
the star-shaped CA(PEG)4 is able to inhibit RBC aggregation. This is in agreement with 
prior studies125, which described an optimum value for the concentration. The extent of 
the inhibition of RBC aggregation shows a dependence on the polymer concentration and 
seems to he influenced by the molar mass as weIL Molar mass between 10 -16 kDa are 
more efficient in reducing RBC aggregation. 
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Figure 4.3. Aggregation of RBCs suspended in autologous plasma measured using a 
Myrenne Aggregometer. Myrenne M at stasis (A) and Ml at 3 S·l (D) aggregation 
values.normalized to control (e.g. buffer added without polymer) and presented as 
indices (± SD) for CA(PEG)4 for each polymer concentration (1.3, 4.0 and 6.7 
mg/mL). Values for M and Ml < 1 indicate inhibition of RBC aggregation. 
Measurements were in duplicate for each donor (n 3). 
82 
Interpretation of these findings in tenns of physicochemical mechanisms is thus 
\ 
of importance, but is limited by the CUITent lack of understanding of the mechanism 
involved in RBC aggregation. As discussed in the introduction, the two models describing 
RBC aggregation are opposing. The "bridging model" predicts increased aggregation 
resulting from an increased polymer concentration at the RBC surface, whereas the 
"depletion model" predicts the opposite.15 It is important to note that the depletion model 
does not require pol ymer adsorption onto the RBC but only requires that the 
concentration of the polymer in the depletion layer be less than the bulk solution to cause 
aggregation. Given the two models for RBC aggregation, it is possible that the star shaped 
CA(PEG)4 decreases RBC aggregation via either decreasing (bridging model) or 
increasing (depletion model) the concentration of the aggregating polymer near the RBC 
surface. However, there has been increasing evidence to support the depletion model for 
polymer-induced RBC aggregation.8,54,60 Therefore, if the depletion model was to be 
applied, it would seem most likely that CA(PEG)4 reduces RBC aggregation via reducing 
the depletion effect near and the RBC soft surface layer (i.e., its glycocalyx). Considering 
the small size of the CA(PEG)4, it is possible that it is able to penetrate the depletion layer 
fonned by the larger pro-aggregating macromolecules (e.g. fibrinogen) such that it is able 
to effectively reduce the osmotic gradient between the intercellular gap and the bulk 
phase.8 
Possible measurement artifacts may have affected the Myrenne data such as 
incomplete disruption of strongly interacting RBCs at high shear rates, and a unifonn cell 
concentration gradient due to non-Newtonian behaviour of the medium.6 
4.1.3 Light microscopy of blood samples with CA(pEG)4 
Microscopie examinations of RBCs incubated in autologous plasma and in 6.67 
mg/mL of CA(PEG)4 are shown in Figure 4.4 . The microscopie examination of the 
morphology indicated that nonnal, discocytic RBC morphology was preserved for all 
samples. No difference in rouleaux structure compared to the control sample (i.e. no 
polymer added) was observed. This implies that polymer does not cause morphological 
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changes to the red cell membranes, wruch is a desired feature for biocompatibility. The 
images of the sample with the CA(PEG)4 polymer did not reveal inhibition of RBC 
aggregation because the sample was further diluted with plasma to obtain a good image. 
It is possible that the dilution with plasma hindered the polymer effect. 
Figure 4.4. Photomicrographs of red blood cells (RBCs) in plasma with CA(PEG)4 
pol ymer at a concentration of 6.67 mg/mL taken at 400 magnification. These are 
enlarged microscopic images and are used for the basis of qualitative observations. 
4.2 The Effeet of Linear PEGs on Human RBCs 
The effect of linear PEGs on blood viscosity at 25°C over a range of shear rates is 
shown in Figure 4.5. The flow curves show non-Newtonian behavior similar to the star-
shaped polymers. Although the sample of the linear PEG 5 kDa appeared to be the most 
effective in reducing blood viscosity, it was not significant (P > 0.05). A similar chart to 
Figure 4.2 was plotted for the linear PEGs and is displayed in Figure 4.6. This plot 
clearly shows that the reduction in blood viscosity is not significant for all linear PEG 
polymers. The same explanation for the variability of the measurements as for the star-
shaped CA(PEG)4 can be applied for the linear PEGs. 
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Figure 4.5. Viscosity profiles of RBCs suspended in autologous plasma at 25°C with 
linear PEGs (6.67 mg/mL). AH flow curves show typical non-Newtonian behavior 
for an aggregating system. Data showed no significance difference with P > 0.05. 
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Figure 4.6. Apparent viscosity ratio (0.15 S-1 / 94 S-I) of RBCs suspended in 
autologous plasma at 25 oC with linear PEGs (6.67 mg/mL). Data are obtained from 
Figure 4.5. 
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4.2.1 Myrenne aggregation data of RBC samples with linear PEGs 
The Myrenne aggregation data were obtained in the same manner as the star-
shaped CA(PEG)4. As indicated in Figure 4.7, the linear PEGs inhibited RBC 
aggregation with increasing concentrations and the effect of inhibition of RBC 
aggregation was greater for the concentrations of 4 and 6.7 mg/mL. The 7.5 kDa linear 
PEG appears to be the most effective in reducing RBC aggregation. The Myrenne 
aggregation data for the linear PEGs are in agreement with studies that have shown that 
between 4 kDa to 6 kDa, linear PEG strongly inhibits RBC aggregation in whole 
blood.6,126 
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Figure 4.7. Aggregation of RBCs measured usmg a Myrenne Aggregometer. 
Myrenne M at stasis (A) and Ml at 3 s-I(B) aggregation values normalized to control 
(i. e. no polymer added) and presented as Indices (mean ± standard deviation) for 
linear PEGs at each polymer concentration (1.3, 4.0 and 6.7 mg/mL). Values for M 
and Ml < 1 indicate inhibition of RBC aggregation and values > 1 indicate 
promotion ofRBC aggregation. Measurements were in duplicate for each donor (n = 
3). 
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4.3 Comparison of CA(PEG)s and Linear PEGs 
Before comparing the results of the star-shaped CA(pEG)4 with the linear PEGs, it 
is important to revisit sorne basic differences between these polymers. As it was shown in 
the characterization of the polymer, star-shaped CA(pEG)4 have a small compact 
structure in solution. However, at sorne higher molar masses, the star-shaped CA(PEG)4 
and linear PEG will have the same size in solution as the effect of the core is diminished 
with increasing chain length. Ideally, comparing the effect of the star-shaped CA(PEG)4 
to linear PEGs on RBC aggregation and blood viscosity should be done on the basis of 
their hydrated size. Approximately, this equates to comparing polymers at an equivalent 
suspending phase viscosity. Examples are given in Figure 4.8 at a high shear rate (94 S-I) 
and a low shear rate (0.15 S-I) for the star-shaped CA(pEG)4 and the linear PEGs at 
different molar masses. It can be seen that, at a constant polymer concentration, star-
shaped CA(PEG)4 yield a lower bulk phase viscosity than the linear PEGs for a given 
molar mass, which is an indication that star-shaped PEGs have a more compacted 
structure in solution than linear PEGs. Though the estimated values for the star-shaped 
CA(PEG)4 appeared lower, they are not statistically significant. 
Figure 4.8 confirms the observation that no interaction between the cholane acid 
core and RBC surface occurred as the relationship between molar mass and inhibition of 
RBC aggregation is similar between star-shaped CA(PEG)4 and linear PEGs. 
The possible mechanisms by which the more compacted CA(PEG)4 polymers affect 
RBC aggregation are complex. It is possible that the CA(PEG)4 with the smaller radii 
infiltrates the interspace between RBCs membrane putative binding sites more efficiently 
than linear PEGs. This hypothesis has been suggested previously with low molar mass of 
polysaccharides, which occupy such sites and thereby reduced RBC aggregation.7 
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Figure 4.8. Mean viscosity at a high shear (94 S-I) and a low shear (0.15 S-I) ofRBC 
samples suspended at 40% hematocrit in plasma at 25°C at a polymer concentration 
of 6.67 mg/mL for linear PEGs (.) and CA(PEG)4 (.). Data are presented as mean ± 
standard deviation for n = 3. 
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To assess the hypothesis that the cholane core of CA(PEG)4 shows greater 
inhibition of RBC aggregation due to the absorption of the cholane-core to the RBC 
membrane, a positive control, monofunctional succinimidyl propionate derivative of 
monomethoxy PEG (mPEG20k-SPA) of a molar mass of 20 kDa was used.127 The 
mPEG20k-SPA reacts with lysine residues and terminal amines of proteins. The reaction 
between the activated ester of mPEG20k-SPA and amino groups forms a stable amide 
linkage. The covalent modification of RBCs with PEG produced immunologically 
attenuated cells that may reduce the risk of allosensitization in chronically transfused 
patients. 128 
The effects of CA(PEG)4 and mPEG20k-SPA on blood viscosity at 37°C over a 
range of shear rates are shown in Figure 4.9. The RBCs that were incubated with 
CA(PEG)4 in autologous plasma show no difference from the control sample. The RBC 
samples with the reactive linear PEG, mPEG20k-SPA, shows negligible RBC aggregation 
and a marked reduction (>60%) in low shear blood viscosity when compared to the 
control. This data is an agreement with a previous study that has shown that coated RBCs 
with monomethoxy PEG, molar mass 5 kDa and activated with cyanuric chloride, 
inhibited RBC aggregation and could reduced low shear blood viscosity.127 They also 
showed that the reactive PEG reduced the viscosity by 30% more than the Poloxamer 188 
(Pluronic F-68, 8.4 kDa) which has shown to be beneficial in clinical studies for the 
treatment of pain in sickle cell crisis. JO This implies that covently "coating" RBCs with 
PEGs prevents the cells from adhering to each other hence reducing the RBC aggregation 
extent. 
AIso, these observations suggest that no interaction/adsorption occurs between the 
cholic acid core and the RBC surface. If adsorption did occur, the flow curves of the 
CA(PEG)4 would be betweenthat of the control and linear reactive PEG but that was not 
observed (Figure 4.9). Therefore the inhibition of RBC aggregation hence the reduction 
of low shear blood viscosity observed for the CA(PEG)4 samples is most likely due to the 
polymer-polymer steric repulsion of the hydrated PEG chains between adjacent RBCs. 
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Figure 4.9. Viscosity profile of RBCs suspended in plasma at 37 oC over a range of 
shear rates (0.01 - 94.5s -1). Measurements were in duplicate for each donor (n = 2). 
Figure 4.10. Photomicrograph images of RBCs in plasma at 40X magnification. 
Normal rouleaux formation was observed in control and CA(PEG)4 samples. 
Minimal rouleaux formation was observed for mPEG20k-coated RBCs. 
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Microscopie examinations of RBCs suspended in plasma are shown for 
mPEG20k-SPA-coated RBCs and control (Figure 4.10). The mPEG20k-SPA-coated 
RBCs show minimal rouleaux formation compared to the control. Normal, discocytic 
RBC morphology was observed in all samples. 
In overview, our results indicate that star-shaped CA(PEG)4 can reduce RBC 
aggregation in a similar manner to the linear unreactive PEGs. The inhibition of RBC 
aggregation is dependent on concentration, molar mass, and molecular size. Though, the 
effect on the blood viscosity was not different for both linear and star-shaped PEGs. AIso, 
the CA(PEG)4 polymers do not adsorb or bind to the RBC's surface as it was 
demonstrated with the activated PEG, mPEG20k-SPA, which showed marked decreased 
in whole blood viscosity. 
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CHAPTER 5: CONCLUSION 
5.1 Preparation of CA(PEG)4 
The objective of this work was to use a star-amphiphilic PEG polymer with cholic 
acid derivative as core (CA(PEG)4) and as a therapeutic polymer for inhibiting RBC 
aggregation. The hypothesis was that the star-shaped CA(pEG)4 polymer would be better 
than linear PEGs due to its small hydrodynamic size and solution viscosity. AIso, it was 
suggested that these polymers would be more biocompatible than the block copolymer 
Pluronics, which has been clinically used to reduce RBC aggregation but had sorne 
adverse reactions. 
A series of molar masses of star-shaped CA(PEG)4 polymers were synthesized by 
anionic polymerization. The high molar mass polymers presented sorne bimodal 
characteristics in the SEC traces, which are evident of early chain terminations that were 
present during polymerization. Despite the difficulty in obtaining controlled high molar 
mass, anionic polymerization of the star-shaped CA(PEG)4 provided narrowed molar 
mass distributions. The characterization of their molar mass distributions by MALDI-
TOF proved to be accurate for small molar masses « 5 kDa) but not for the higher molar 
fractions. Therefore, for higher molar masses, SEC alone and SEC-MALLS proved to be 
accurate. The SEC-MALLS provided additional information about the star-like 
architecture. The hydrodynamic radius of the polymers obtained from the intrinsic 
viscosity measurements confirmed the small and compact structure of the star shaped 
polymers « 2 nm). The polymers also demonstrated shear-thinning behaviour in water 
and inPBS. 
The extent of the inhibition of RBC aggregation by the star-shaped CA(pEG)4, 
with the Myrenne aggregation data showed significant reduction when compared to the 
control sample, which was dependent on the concentration. However, these observations 
were not consistent with the blood viscosity measurements which showed no differences 
with the control samples. In comparison to linear PEGs, the effects on RBC aggregation 
and blood viscosity were not different. Under the conditions studied, neither does the 
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CA(PEG)4 appear to absorb on the membrane ofRBCs, meaning that it behave in same 
manner as a linear PEG regardless of its compact structure and low solution viscosity. 
Additional tests with a large controlled groups and patients with abnormal RBC 
aggregation could assess the real effect of the star-shaped CA(PEG)4 polymers on RBC 
aggregation and blood viscosity. 
Since limited success has been aehieved by simply ineubating blood with the 
CA(PEG)4, eovently binding the CA(PEG)4 to the RBC's membrane by means of reactive 
groups such as sueeinimidyl propionate could prove to be a more promising avenue in 
reducing RBC aggregation. Covalently linking star-shaped CA(PEG)4 could allow high 
surface coverage of RBC's membrane and thus preventing non-specifie interactions with 
biologieal systems, whieh could lead to even better immune responses. 
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APPENDIXI 
Steady Laminar Flow 
The relationship hetween vessel diameter and/or blood viscosity and their 
influence on blood flow can he best described by the Hagen-Poiseuille equation:129 
·r4 • 7f Q=P--
8·7J·L 
(a1.1) 
where Q is the rate of flow, P is the pressure, r the radius, 7J the viscosity, and L, the 
vessel length. According to Equation (a.Ll), blood flow in a capillary is directly 
proportional to the pressure and the diameter with power of 4, and indirectly proportional 
to the viscosity and the length of the blood vessel. This implies that the vessel diameter 
may be more important than viscosity for normal blood flow. Poiseuille law is only valid 
under a constant pressure gradient and when the blood flow is defined as laminar flow of 
a homogenous fluid in a rigid cylindrical tube. Thus, in the vascular systems the 
Poiseuille law only serves as a mathematical approximation of the in vivo model of blood 
flow. 
Disorders Related to Abnormal RBC Aggregation 
Sickle cell disease (SCD) is one of the most important clinical hemapathologies. It 
is an inherited blood disorder that affects red blood cells and is common among African-
American, Africans, natives of central India, Mediterranean, and natives of the Middle 
East. 130 People with sickle cell disease have red blood cells that contain mostly 
hemoglobin *s, an abnormal type of hemoglobin that arises from a point mutation in the 
beta-globin chain gene. Sometimes these red blood cells become sickle-shaped (crescent 
shaped) and have difficulty passing through capillaries (Figure a1.1). When sickle-
shaped cells block small blood vessels, less blood can reach that part of the body. A tissue 
105 
that does not receive a nonnal blood flow eventually becomes damaged. Periods of 
painful crisis in sickle cell disease are associated with alteration of the circulating red cell 
population with elevated levels of fibrinogen and plasma viscosity.13I Sickled RBCs get 
entrapped in the microcirculation, thereby causing ischemia or organ damage throughout 
the body. Standard treatments are aimed at relieving sorne symptoms and inc1ude oxygen, 
analgesics, fluid therapy, and blood transfusion. However, there is currently no universal 
cure for sickle cell disease and blood transfusion accompanied by pol ymer coating of 
RBCs to inhibit aggregation would certainly be c1inically beneficial if such coating 
strategy is succeeding. 
o Norm~1 red blood CQlIs 
hocn~lobl" 
r..:lrm:;ll.;andJo 
!h.)t~ 
~...:JOo !;h .1pe 
Figure a1.1. (A) Nonnal red blood cells flow freely in a blood vessel. The inset image 
shows a cross-section of a nonnal red blood cell with nonnal hemoglobin. (D) Abnonnal, 
sickled red blood cells c1ump and block the blood flow in a blood vessel. The inset image 
shows a cross-section of a sickled red blood cell with abnonnal strands of hemoglobin. 
Taken from ref. 132 
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Cardio vascular diseases 
Cardio vascular disease is one of the clinical disorders for which the effect of 
hemorheological consequences has been weIl established. The observable outcomes of 
cardio vascular diseases such as increased blood viscosity, increased RBC aggregation, 
and impaired RBC deformability have been reported.5 For instance, ischemic diseases of 
various organs are known to be associated with blood flow impairment. 133 
Diabetes mellitus 
Diabetes mellitus is a disease of metabolic malfunction, most notably abnormal 
glucose metabolism, accompanied by characteristic long-term complications. The 
complications of diabetes mellitus represent microcirculatory disorders and damage many 
types of tissues including nerves, skin, retina, heart, kidney, and brain. In all these tissues, 
the major cause of damage is vascular disease affecting both microvasculature and 
macrovasculatrure. Diabetes mellitus is affected by a microcirculatory disturbance which 
gives rise to higher blood and plasma viscosity, enhanced RBC aggregation, and impaired 
RBC deformability. Both the velocity of rou/eaux formation and the cohesion of the 
rouleaux network are significantly elevated in diabetic patients. Plasma viscosity and 
whole-blood viscosity measured at a low shear rate (0.95 S-I) are also significantly 
elevated in the diabetic group? Another study showed that an increased in RBC 
aggregation may be a mechanism by which sorne cardiovascular risk factors could 
promote cardiovascular disease in diabetes. 1 
Sepsis syndrome 
Sepsis syndrome represents one of the most dramatic disturbances in 
hemorheological and is a leading cause of death in non-coronary intensive care units 
worldwide. The sepsis syndrome is a complex systematic inflammatory condition 
associated with infection. Both clinical and experimental studies showed that sepsis is 
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significantly marked by increased in RBC aggregation and impaired RBC 
deformability.134,135 These deformabilities may lead to severe vascular problems 
encountered in sepsis syndrome such as impaired oxygen de1ivery to tissues and organ 
failure. 
Thalassemia 
Thalassemias are inherited disorders characterized by a defective production of 
the globin chain subunits of hemoglobin. 130 In alpha or beta thalessemia, the alpha or 
globin chain is reduced or absent. Major thalessemic syndromes are associated with 
morphological and functional RBC anomalies, leading to shortening of the red cells life 
span and chronic anemia. It has been reported that major thalessemia patients exhibit 
enhanced aggregability forming large c1usters, and higher-than-normal shear force is 
required to disperse these aggregates. 136 Thalessemias are most commonly in people form 
Southeast Asia and China, Mediterranean origin, and Blacks.13o These areas were 
historically affected by malaria. This thought to be because the RBCs of people diseased 
with Thalessemia are relative1y resistant to infection with the malaria parasite. 
Obesity 
The prevalence of obesity is a concem today especially in North America. 
Morbidly obese patients or those that qualify for bariatric surgery possess a severe risk for 
deep vein thrombosis and pulmonary embolism. RBC rheological properties play an 
instrumental role in determining the blood-flow resistance in micro circulation and RBC 
hyperaggregation has a significant influence on the microcirculation blood flow, both are 
determinant factors in whole blood viscosity and are known to be altered in obese 
patients. Obesity is associated with an increase in the degree of aggregation and a 
decrease in RBC deformability as well as an alteration in the RBC aggregation kinetics. 23 
The deformability factor is important in RBC aggregation because it leads to a shear-
dependent-behaviour of blood viscosity and minimizes the blood-flow resistance in 
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capillaries. Thus the necessity to introduce a therapy to correct or improve RBC 
rheological properties, which in turn may improve blood flow in microcirculation and 
prevent post-operative complications after bariactric surgery, is a need. 
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APPENDIX2 
Differentiai Scanning Calorimetry (DSC) 
DifferentiaI scanning calorimetry (DSC) is a technique that measures heat flow 
into or out of a material as a function of time or temperature. Polymer crystallinity can be 
determined with DSC by quantifying the heat associated with melting (fusion) of the 
polymer. In DSC the sample and the reference pan (usually an empty pan) are heated at 
the same rate to keep the temperature identical (Figure a2.1). The heater output at the 
sample is different from the reference. The heat output difference, which depends on 
differences in heat capacity (amount of heat it takes to get temperature increase), is 
plotted as a function of temperature. A preheated purge gas is present to provide 
additional baseline stability as well as the desired sample/atmosphere interaction. 
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Figure a2.1. Representation of Differentiai Scanning Calorimetry (DSC). 
The heat capacity changes at the glass transition (Tg.). Glass transitions may occur 
as the temperature of an amorphous solid is increased. These transitions appear as a step 
in the baseline of the recorded DSC signal. This is due to the sample undergoing a change 
in heat capacity; no formaI phase change occurs. As· the temperature increases, an 
amorphous solid will become Iess viscous. At sorne point the molecules may obtain 
enough freedom of motion to spontaneously arrange themselves into a crystalline form. 
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This is known as the crystallization temperature (Tc) (Figure al.l). This transition 
from amorphous solid to crystalline solid is an exothermic process, and results in a peak 
in the DSC signal. As the temperature increases the sample eventually reaches its melting 
temperature (Tm). The melting process results in an endothermic peak in the DSC curve. 
The ability to determine transition temperatures and enthalpies makes DSC an invaluable 
tool in producing phase diagrams for various chemical systems. 
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Figure a2.2. Schematic differential Scanning Calorimetry (DSC) demonstrating 
the appearance of several common features 
Determination of the molar mass 
Polymers are a chain consisting of large molecules made up of a linked series of 
repeated simple monomers. The individual polymer chains rarely have the exact same 
degree of polymerization and molar mass, and there is always a distribution around an 
average value. The molar mass distribution (or molecular weight distribution) in a 
polymer describes the relationship between the number of moles of each pol ymer species 
(N;) and the molar mass (M;) of that species. 
As a consequence of the molar mass distribution (Figure a2.3), different 
techniques can yield different molar mass values. Colligative properties such as size 
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exclusion chromatography depend on the number of molecules in solution, and such 
properties correspondly yield a number-average molar mass Mn as given by 
(al.1) 
where NA is the Avogadro number, 6.023 x 1023 molecules/mole. In a distribution of 
molecular weights, the number average is bias for the lower values. 
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Figure a2.3. Distribution of molar mass in a typical polymer. 
Figure a2.3 shows a graph of molecular weight distribution for a typical polymer. 
Polymers with a narrow spread in molecular weights can be obtained by anionic 
polymerization or other living polymerization techniques. 
Sorne experimental methods for the determination of molecular weight depend on 
the masses or size of the solute molecules, rather then their number. An example of such 
method is in light scattering (LS) and the weight-average molar mass, Mw is given by 
(al.2) 
The ratio, M;6n is known as the polydispersity index (PDI). Polymers produced by 
free radical polymerization give a ratio of 2. However, polymers produced by anionic 
polymerization may he almost unity or monodisperse as it is technically referred. 
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Size Exclusion Chromatography 
This technique depends on the size of the polymer in solution. The stationary 
phase is composed of crosslinked polymers which contain surface pores of various sizes 
(Figure a2.4). The large molecules do not fit into the pores so they travel fast whereas the 
small molecules travel slower because they are retained longer. 
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Figure a2.4. Diagram of size exclusion chromatography (SEC). 
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The molar mass-Iog retention volume plot can be used to determine the molar 
mass and molar mass distribution of a pol ymer sample if monodisperse calibration 
standards are available for that polymer. 137 The SEC chromatogram of a polymer will 
show a broad peak. The broadening effect is a result of the large number of unresolved 
oligomers in the samples. Commercially available SEC software is able to divide the peak 
into a number of slices. Each slice has a retention volume, VR; and if the slice is 
sufficiently narrow, it can be assumed to be effectively monodisperse and to have a molar 
mass M; which can be read off the calibration plot, to give molar mass of the pol ymer as a 
function of VR• The software also determines the area Ai of each slice. Since the area of 
each slice is proportional to the weight of the polymer as a function of VR, the software 
integrates it to produce the cumulative weight percent. Finally, the software makes the 
cross-plot of cumulative weight percent vs. log M, which is the molar mass distribution. 
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Size exclusion chromatography with multiangle laser light scattering 
(SEC-MALLS) 
Coupling the SEC instrument with molecular weight sensitive laser light-
scattering overcomes the need of a calibration and yields absolute molecular weights 
provided that the value dn/dc (differential refractive index increment) or the total mass of 
the eluting solute is known. In the SEC-MALLS system as shown in Figure a2.S DAWN 
EOS photometer is attached to a pump system. Polymer solutions injected to the system 
are brought downstream to the columns by the mobile phase for fractionation. When the 
eluent leaving the column flows through the MALLS, light scattering measurements are 
made almost simultaneously at each different angle photometer and are recorded before 
passing through the differential refractive index detector (DRI) where their concentrations 
are quantified. Data collection and processing are generated by the Wyatt Technology 
Corporation ASTRA. SEC-MALLS provides the molecular weight distribution, 
branching information, and molecular information (Rn, Rg). 
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Figure a2.S. Simplified diagram ofSEC-MALLS set-up 
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) 
mass spectrometry 
MALDI-TOF mass spectrometer (Figure a2.6) is a relatively novel in which a co-
precipitate of an UV -light absorbing matrix and a macromolecule is irradiated by a 
nanosecond laser pulse. Most of the laser energy is absorbed by the matrix, which 
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prevents unwanted fragmentation of the macromolecule. The ionized macromolecules 
are accelerated in an electric field and enter the flight tube. During the flight in this tube, 
different molecules are separated according to their mass to charge ratio and reach the 
detector at different times. In this way each molecule yields a distinct signal. The method 
is used for detection and characterization of macromolecules, such as proteins, peptides, 
and polymers. The mJz scale of the mass spectrometer is calibrated with a known sample 
that can either be analyzed independently (external calibration) or pre-mixed with the 
sample and matrix (internal calibration). The analyzer and detector of the mass 
spectrometer, and often the ionisation source too, are maintained under high vacuum to 
give the ions a reasonable chance of traveling from one end of the instrument to the other 
without any hindrance from air molecules. 
'--
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Figure a2.6. Simplified diagram ofMALDI apparatus and output (Taken from 138) 
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Figure. a3.1. NMR spectra of CA(PEG)4 of sample 1 seeTable 2.1 for details. 
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Figure. a3.2. NMR spectra of CA(pEG)4 of sample 2 seeTable 2.1 for details. 
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Figure. a3.3. NMR spectra of CA(PEG)4 of sample 3 seeTable 2.1 for details 
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Figure. a3.4. NMR spectra of CA(PEG)4 of sample 4 seeTable 2.1 for details 
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Figure. a3.5. NMR spectra of CA(PEG)4 of sample 5 seeTable 2.1 for details 
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Figure. a3.6. NMR spectra of CA(PEG)4 of sample 7 seeTable 2.1 for details 
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Figure. a3.7. NMR spectra of CA(PEG)4 of sample Il seeTable 2.1 for details 
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